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ABSTRACT
ALTERNATIVE THERAPY AND TREATMENT OF TYPE 2 DIABETES
By
Carmine R. Grieco, MS
Old Dominion University, 2012
The rise in prevalence and incidence of type 2 diabetes mellitus (T2D) in the developing
world continues unabated. Current treatment strategies, however, fall short of achieving optimal
glycemic control. The aim of project I was to investigate the effect of an acute bout of a yogic
breathing exercise on heart rate variability (HRV) in individuals with T2D. Project II was
designed to assess the effectiveness of the neurohormone melatonin in lowering short- and longterm glucose levels, lipids and oxidative stress in T2D. Project III investigated the differential
effects of two different styles of aerobic exercise on postprandial glycemia, mood and HRV in
T2D.
Project I investigated the effect of short-term breathing exercises and demonstrated significant
differences between the T2D group and an age-matched normoglycemic group (CON) in resting
measures of HRV. Standard deviation of consecutive heart beats (SDNN), the square root of the
mean squared differences (RMSSD) and total spectral power (TP) were almost uniformly lower
in the T2D group than the CON group. A within-group analysis revealed no significant effect of
breathing exercise upon HRV in the CON group. However, a 10-minute breathing protocol
involving selective breathing through only the left nostril demonstrated a significant reduction in
resting heart rate in the T2D group (-1.2 beats per minute, or bpm) compared to the heart rate
average during the entire breathing protocol, indicating a possible acute improvement in vagal
tone.

Project II, which investigated the effect of six weeks of melatonin supplementation on shortand long-term glycemic control, lipids, and oxidative stress in T2D, yielded impressive results.
There was a significant reduction in malondialdehyde, a marker of oxidative stress (-6.3 vs.
0.7nmol/ml), as well as a significant drop in glycated hemoglobin (-0.24%±0.23) in the
melatonin group vs. the placebo group.
Project III examined the impact of a more recreational style of exercise (table tennis)
following a dinner meal vs. a more traditional exercise (walking). Our results indicated that selfpaced walking generated a significantly higher heart rate than table tennis, which translated into
a significant drop in blood glucose levels following a 30-minute bout of exercise. We did not,
however, note any difference in mood between the two groups.
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CHAPTER 1
INTRODUCTION

Currently it is estimated that 11.3% of adults over the age of 20 years and nearly 27% of
adults over the age of 60 years have diabetes, with type 2 diabetes mellitus (T2D) accounting for
90-95% of all cases (CDC, 2011). Furthermore, the ranks of the diabetic population are swelling
rapidly and it is predicted that the number of people with diabetes will nearly double within the
next three decades (Chaturvedi, 2007). Additionally, it is estimated that 35% of the U.S. adult
population is prediabetic (CDC, 2011). Complications arising from T2D represent a significant
burden upon the national healthcare system, accounting for approximately 18.5% of all health
care expenditures in 2002 (ADA, 2003).
The primary goal for the treatment and prevention of T2D is optimal glycemic control. T2D is
characterized by a hyperglycemia-driven increase in oxidative stress (Giugliano and Ceriello,
1996), as well as a reduction in antioxidative capacity (Rysz et al., 2007). This dual attack
contributes to autonomic nervous system damage (Singh et al., 2000), which can subsequently
affect any organ of the body (Vinik and Erbas, 2001). It also results in micro- and
macrovascular disease (Fowler, 2008). Consequently, individuals with T2D are 2-4 times more
likely to die from heart disease and twice as likely to die of all-cause mortality (CDC, 2011).
There are a plethora of pharmacological agents designed to treat hyperglycemia. However,
pharmacotherapeutic tactics still fall short of maintaining optimal glycemic control (Cefalu et al.,
2009). In fact, only 37% of patients with T2D achieve and maintain optimal glycemic control
(Saydah et al., 2004). A potential complicating factor is the economic cost of anti-diabetic drugs.
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For example, it has been shown that oral antidiabetic drug use is inversely associated with
adherence and a significant predictor of treatment failure (Barron et al., 2008).
It has been proposed that future directions of therapy should target the fundamental defects
associated with T2D (Cefalu, Richards and Melendez-Ramirez, 2009). These fundamental
properties are hyperglycemia and the resultant increase in oxidative stress, which, according to
Brownlee's (2000) "unifying hypothesis," is the single most critical factor in complications of
T2D. While exercise is a cornerstone treatment and has been previously validated for both
treatment and prevention of T2D (Colberg et al., 2010), it has been demonstrated that individuals
with T2D are less likely to engage in adequate amounts of physical activity (Nelson et al., 2002).
Furthermore, adherence rates among individuals with T2D are distressingly low as well (Serour
et al., 2007).
Current research into alternative and/or adjunctive therapy for T2D is sparse, but promising.
Yoga training, for example, is associated with a higher adherence rate than traditional training
(Flegal et al., 2007). The timing of exercise interventions around meal consumption is likewise a
promising avenue of study as postprandial hyperglycemic spikes have demonstrated a greater
impact on overall glycemic control than fasting glycemia (Woerle et al., 2007). Melatonin, a
neurohormone and recently recognized antioxidant, has established a significant track record of
reducing markers of oxidative stress in animal models and in in vitro studies (Korkmaz et al.,
2009).
Therefore, further research into cost-effective alternative therapies, used in conjunction with
standard pharmacotherapy, is warranted. Through the selective targeting of the fundamental
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mechanisms which are responsible for the majority of complications arising from T2D it may be
possible to more effectively treat and/or prevent this disease.
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Project I
The Acute Effect of Short-Term Breathing Exercises on Sympathovagal Balance in Type 2
Diabetes

Statement of Purpose
The purpose of this study was to determine if a commonly practiced style of yoga breathing,
alternate nostril breathing (ANB), significantly alters indices of heart rate variability (HRV) in
individuals with T2D and an age-matched, normoglycemic control group.

Research Hypotheses
1. Baseline measures of all HRV measurements (SDNN, RMSSD and TP) will be reduced in
the T2D group in comparison to the control group (CON).
2. ANB will induce significantly greater increases in SDNN, RMSSD and TP in the T2D group
in comparison to the CON group.
3. The T2D group will have significantly greater heart rate response during the stand challenges
(First and Last Stand) than the CON group.

Assumptions
1. All participants will adhere to the recommendations of abstaining from food for a minimum
of three hours prior to testing.
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2. All participants will adhere to the recommendations of abstaining from caffeine-containing
foods and beverages on the day of testing.

Limitations
1. HRV is influenced by psychological as well as physical phenomena. It is not possible,
however, to standardize mood or affective state.

Delimitations
1. Participants in the T2D group have diagnosed type 2 diabetes.

Operational Definitions
1. Heart rate variability (HRV) - Fundamentally, HRV represents the difference, in
milliseconds, between consecutive heart beats. This inter-beat interval reflects dynamic
cardiovascular control.
2. SDNN - The standard deviation of the normal-to-normal consecutive heart beats represents a
global measure of the variability within the cardiac cycle.
3. RMSSD - The square root of the mean squared differences of successive normal heart beats.
This is a measurement of HRV that is reflective of parasympathetic or vagal input.
4. TP - Total spectral power is a frequency domain method of quantifying all cyclic
components of heart rate variability and is expressed in ms2.
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Project II
The Effect of N-Acetyl-5-Methoxytryptamine (Melatonin) Supplementation on Glycemic
Control, Lipid Metabolism, and Oxidative Stress in Type 2 Diabetes Mellitus

Statement of Purpose
The purpose of this investigation is to evaluate the effect of a commercially available
preparation of melatonin on glycemic control, lipid metabolism, and oxidative stress in
uncomplicated T2D.

Research Hypotheses
1. There will be significantly greater reductions in fasting glucose levels in the melatonin
supplemented group than the placebo group.
2. There will be significantly greater reductions in glycated hemoglobin (AlC) in the melatonin
supplemented group than the placebo group.
3. There will be significantly greater reductions in malondialdehyde in the melatonin
supplemented group than the placebo group.
4. There will be significantly greater reductions in total cholesterol in the melatonin
supplemented group than the placebo group.
5. There will be significantly greater reductions in low density lipoprotein in the melatonin
supplemented group than the placebo group.
6. There will be a significantly greater increase in high density lipoprotein in the melatonin
supplemented group than the placebo group.
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7. There will be significantly greater reductions in triglycerides in the melatonin supplemented
group than the placebo group.

Assumptions
1. The melatonin capsules, a commercially prepared product, have been correctly verified for
potency.
2. Participants will faithfully ingest one pill every evening, 30 minutes prior to sleep every
night of the study.

Limitations
1. This investigation did not perform blood analyses to quantify markers of antioxidant activity.
2. The commercially produced melatonin capsules were verified via high performance
chromatography by the manufacturer.

Delimitations
1. All participants must have a prior diagnosis of type 2 diabetes.
2. All participants must follow a standard diurnal cycle (i.e., no overnight work pattern).
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Project III
The Effects of Walking vs. Table Tennis on Postprandial Glycemia, Heart Rate Variability,
and Mood in Type 2 Diabetes

Statement of Purpose
The purpose of this study is to compare a traditionally prescribed exercise activity (i.e.,
walking) to a more recreational form of exercise (table tennis) on postprandial glycemic control,
heart rate variability and mood in individuals with uncomplicated T2D.

Research Hypotheses
1. There will be significantly greater reductions in postprandial glucose levels in the table tennis
treatment than the rest or walking treatments.
2. There will be significantly greater improvement in sympathovagal balance in the table tennis
treatment than the rest or walking treatments.
3. A bout of table tennis will increase mood state to a significantly greater degree than an equal
amount of time walking or resting.

Assumptions
1. Participants are not under unusual amounts of psychological stress as this can negatively
impact HRV measurements.
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Limitations
1. The self-selected pace of treadmill walking is not relative to the fitness level of the
individual.

Delimitations
1. Participants are capable of undertaking 30 minutes of continuous exercise.
2. Participants have previously diagnosed type 2 diabetes

Operational Definitions
1. Mean RR - The interbeat interval, measured in milliseconds, from one QRS complex to the
next
2. SDNN - the standard deviation of normal RR intervals
3. RMSSD - the square root of mean squared differences among consecutive normal RR
intervals
4. Sympathovagal balance - A ratio-based representation of the independent influence of the
sympathetic (low frequency power) and parasympathetic (high frequency power) inputs as
reflected in the cardiac cycle
5. Valsalva ratio - The ratio between the slowest and fastest heart rate following a valsalva
maneuver (a sustained exhale against pressure)
6. E/I ratio - The ratio of the longest RR interval during exhalation by the shortest RR interval
during inspiration
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th
7. 30:15 ratio - A ratio based on the slowest heart rate after standing (typically at the 30 beat)
by the fastest heart rate (typically at the 15th beat)
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CHAPTER II

REVIEW OF LITERATURE
The following review of literature will explore evidence as it relates to several specific
aspects of alternative therapy for the treatment and prevention of T2D. There is significant
literature established concerning the complications arising from T2D as well as mechanisms of
action relating to the pathology of T2D, but there is still a significant need for research into
alternative therapies for the treatment and prevention of T2D. This chapter will discuss the role
of several individual alternative treatment interventions, provide a review of literature, and
establish the need for further research in alternative treatments for T2D.

PROJECT I
The Acute Effect of Short-Term Breathing Exercises on Sympathovagal Balance in Type 2
Diabetes

Heart Rate Variability
HRV represents the changes that occur in the inter-beat intervals between successive cardiac
cycles. Intrinsic heart rate is governed by the sino-atrial (SA) node, located in the right atrium of
the heart. The instantaneous heart rate, however, represents the neurohumoral balancing of both
sympathetic and vagal inputs. In the absence of autonomic input the SA node creates a
spontaneous depolarization of the myocardium, which results in a heart rate in excess of 100
beats per minute (Jose et al., 1970). Autonomic inputs modify this base rate of cardiac cycles,
with sympathetic and vagal inputs acting in a coordinated manner to adjust cardiac output
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according to bodily needs. Therefore, in a resting state instantaneous heart rate represents either
an increase in vagal dominance, sympathetic withdrawal, or a combination of the two.
HRV measurements of time and frequency domain are most commonly used in the literature
(Task Force, 1996). Time domain measurements are the simplest form of calculating variability
within the cardiac signal and revolve around statistical methods of measuring variance within
time periods between successive QRS complexes (ventricular depolarization). Common time
domain measurements include standard deviation of the normal-to-normal spontaneous cardiac
cycles (SDNN) and the square root of the mean squared differences among successive cardiac
cycles (RMSSD). The SDNN is a global measure of variability, while the RMSSD is thought to
reflect only the vagal influence. Frequency domain measurements are statistical descriptions of
power spectral density, a metric of how variance is distributed as a function of the frequency
within the signal. Commonly cited measurements of frequency are low frequency power (LFms ;
0.04-0.15Hz), high frequency power (HFms2; 0.15-0.40Hz) and total spectral power (TPms2;
>0.40Hz). The interpretation of LF power is somewhat controversial, with some parties
considering it a marker of sympathetic power and others a combination of both sympathetic and
vagal power. HF power, however, is seen as a marker of vagal activity, while TP is regarded as a
marker of total variance.

Heart Rate Variability and Relationship to Diabetes
A loss of HRV is associated with T2D and prediabetes and is inversely associated with
plasma glucose levels (Singh et al., 2000). In fact, in a recent study of 1,987 older individuals
(55-74 years), Ziegler et al. (2006) determined that the primary factor predicting decreased HRV
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was presence of diabetes. Both loss of HRV and resting tachycardia are common signs of
autonomic neuropathy of the cardiovascular system (Vinik and Erbas, 2001) and may be an early
predictor of macrovascular disease in T2D (Gottsater et al., 2006). Decreasing HRV is also
associated with increasing carotid artery atherosclerosis in T2D (Gottsater et al., 2006). More
specifically, decrements of vagal activity appear early in T2D, manifest as diastolic dysfunction
and may contribute to the high incidence of cardiovascular disorders in T2D (Poirier et al.,
2003). Therefore, measurement of HRV represents a simple and non-invasive tool which is
useful for understanding the status of the autonomic nervous system in T2D (Acharya et al.,
2006).

Training Effect of Breathing Exercises on Cardiovascular Control
Several investigations support the concept that yogic breathing exercises (pranayama) may
have an ability to influence cardiovascular control via the autonomic nervous system. In an early
study by Telles et al. (1994), 48 young (34.1±5.9 years), healthy male subjects who were yoga
teachers in-training were randomly assigned to one of three groups for a four-week intervention
that consisted of the following breathing exercises conducted four times daily: right nostril
breathing (RNB), left nostril breathing (LNB) or alternate nostril breathing (ANB). Subjects
performed 27 respiratory cycles of the assigned breathing exercise four times per day, for 30
consecutive days. Following training the RNB group showed a significant increase in resting
oxygen consumption (37%, p<0.05). In contrast, the LNB group demonstrated a significant
increase in galvanic skin resistance, indicating a reduction in sympathetic outflow to the sweat
glands. Interestingly, both the ANB and RNB groups displayed a significantly higher resting
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heart rate of 1.9 and 2.8 beats per minute (bpm), respectively, at the conclusion of the four-week
intervention (p<0.001).
In a study of similar duration, Dhungel et al. (2008) enrolled 36 young (24.7±2.4 years),
predominantly male subjects (32 male, 4 female) in an investigation of ANB, conducted daily in
15 minutes sessions, on cardiovascular function. At the conclusion of the four-week intervention
there were significant decreases in respiratory rate (-2.1 bpm, p<0.001) and diastolic blood
pressure (DBP) (-5.1mm/Hg, p<0.001) and an increase in peak expiratory flow rate (12.2L/min,
p<0.001). However, in contrast to Telles et al. (1994), the present investigation realized a
significant decrease in resting heart rate (-3 bpm, p<0.001).
In a more elegant study, Srivastava et al. (2005) investigated both the acute and chronic effect
of ANB between equal groups of young males and females (n=20 each). The acute effect was
assessed following a single 15-minute bout of ANB. This was followed by eight weeks of 15
minutes of daily practice. Acutely the single bout of ANB decreased heart rate in females (-10
bpm, p<0.0001), but not males. Contrarily, the males realized a significant decrease in systolic
blood pressure (SBP) (-2.3 mmHg, p<0.05), but the female subjects did not. Following eight
weeks of daily training both male and females demonstrated significant drops in resting heart
rates (-12.6 and -11.7, respectively, p<0.001). Similarly, both genders significantly decreased
SBP. However, contrary to the acute effect, females demonstrated a significant drop in DBP,
while the males DBP (which was acutely lowered) rose to non-significance following training. In
contrast to Telles et al. (1994), neither gender demonstrated an acute or training effect upon
galvanic skin resistance.
In a study that more directly assessed autonomic function, Pal et al. (2004) randomly assigned
60 healthy, young (17.7±0.2 years) subjects to either a fast (FB) or slow (SB) breathing group for
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a three-month intervention. Each group was further divided into experimental or control groups
(n-15 each). The FB group practiced 60 minutes daily by performing one minute of deep and
fast inspiration and expiration, followed by a three-minute rest period. This process was repeated
eight to ten times throughout the two daily 30-minute sessions. The SB group performed two
daily sessions of 30 minutes each in which they practiced slow (6 breaths per minute) ANB. The
control groups (CON) participated in no breath training. There were no significant changes in
any variable in the FB group or the two CON groups. In contrast, the SB group had a significant
decrease in resting HR (-8 bpm, p<0.05), maximum heart rate response to standing (-10.1 bpm,
p<0.05), minimum heart rate response to standing (-8.1 bpm, p<0.01), and mean heart rate after
standing (-8.0 bpm, p<0.01). Collectively these decreases would suggest an improvement in
vagal tone.
Recently, Veerabhadrappa et al. (2011) investigated the effect of Mukh Bhastrika (a fastpaced pranayama) on resting heart rate, blood pressure response to standing, and heart rate
response to deep breathing in 50 young (19.5±1.2 years), healthy male participants following 12
weeks of training (5 days per week). The Mukh Bhastrika consisted of a rapid inhalation and
exhalation "like the bellows of a blacksmith" for 10 respiratory cycles. This was followed by a
final exhalation in which the breathing cycle was delayed as long as possible, and followed by a
maximal inhale, after which the participant retained the breath for as long as possible. This
process was repeated three times per session. At the conclusion of the study, there was a
significant decrease in resting heart rate (-13.4 bpm, p<0.001), an increase in both the maximum
(12.5 bpm) and minimum (7.4 bpm) heart rate response to standing (p<0.001, respectively) and a
decrease in systolic blood pressure response to standing (-3.6 mmHg, p<0.001). Since resting
heart rate is a product of vagal drive, a significant decrease in resting heart rate is indicative of an
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increase in parasympathetic activity. Concomitantly, there was a decrease in systolic blood
pressure response to standing. Taken together, these findings would suggest an increase in vagal
tone.
In another recent investigation, Ankad et al. (2011) enrolled 50 subjects covering a
substantially larger age range and gender distribution than previous studies (24 male, 26 female,
20-60 years, mean of 38.6±8.9 years). Significantly, participants with prior yoga history were
excluded from the investigation. Subjects participated in a daily two-hour practice involving 45
minutes of eight different pranayama exercises for 15 days. Each session also involved yogabased lectures (30 minutes) and meditation (20 minutes). Baseline and post-training
measurements of resting heart rate, systolic and diastolic blood pressure and mean arterial
pressure were taken three times during a 30 minute period of rest in a supine position. For
statistical purposes scores were stratified according to gender (male, female), age (>40 and >40
years) and BMI (<25 and >26 kg/m2). There were significant reductions in resting heart rate,
systolic blood pressure, diastolic blood pressure and mean arterial pressure, across all gender,
age, and BMI delineations. While this is indicative of a training response, the results are clouded
by a multifactorial intervention.

Acute Effect of Breathing Exercises on Cardiovascular Control
Perhaps the best evidence linking pranayama to alterations in autonomic function was
conducted by Pramanik et al. (2009). In this investigation 39 subjects of indeterminate gender
underwent pre/post readings of resting heart rate and systolic and diastolic blood pressure
following five minutes of Bhastrika yogic breathing at a rate of 6 bpm (4s inhale/6s exhale).
Another group of 10 subjects ingested 20 mg of hyoscine-iV-butylbromide (Buscopan®), an anti-
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cholinergic that is known to selectively inhibit the effects of parasympathetic activation, 30
minutes prior to performing the same yogic breathing exercise for five minutes. The group which
ingested hyoscine-TV-butylbromide demonstrated no significant change in any variable. However,
the non-supplemented yogic breathing group significantly decreased systolic blood pressure (-7.6
mmHg, p<0.05) and diastolic blood pressure (-4 mmHg, p<0.05). While the heart rate decreased
it did not reach the level of significance. This study demonstrates perhaps the most compelling
evidence linking pranayama to cardiovascular function.
In one of the few published studies measuring parameters of HRV, Raghuraj and Telles
(2008) recruited 21 young (27.5±6.3 years), healthy male volunteers. All subjects had previous
pranayama training (mean 14.6±10.7 months). Subjects participated in five randomly assigned
sessions of 40 minutes on different days. Each 40-minute session was broken down into 4 epochs
of 7.5 minutes, equaling 30 minutes. Each session also began and ended with a five-minute
transition period. During each epoch measurements of HRV were taken during the final five
minutes and during each transition period (equaling six measurements during each session). Each
session included four of the following five possible breathing exercises in random order: (1)
RNB, (2) LNB, (3) ANB, (4) breath awareness, and (5) normal breathing. RNB and LNB had no
significant effect upon measures of HRV. ANB, however, significantly increased low frequency
power (a metric of sympathetic drive) while simultaneously decreasing high frequency power (a
metric of vagal drive).
In another study Raghuraj et al. (1998) examined the acute effect two different styles of yogic
breathing exercises on measures of HRV in young (25.6±3.1 years) and experienced (19.7±12.8
months) yogic practitioners. The two interventions, conducted on separate days, were
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kapalabhati and ANB. Kapalabhati breathing was a rapid and forceful inhalation/exhalation
conducted at a rate of 120 breaths per minute for only one minute. ANB involved inhaling
through a single nostril and exhaling through the opposite nostril at a slow pace (pace not stated).
This sequence was alternated and repeated for 15 minutes. Results indicate the kapalabhati
breathing induced a significant reduction in high frequency power (vagal drive) and a significant
increase in low frequency drive (sympathetic drive). Contrary to Raghuraj and Telles (2008),
ANB did not significantly affect any metric of HRV.
Telles et al. (1996) investigated the differential effects of 45 minutes of RNB compared to an
equal period of normal breathing (NB) in 12 young (27.2±3.3 years) experienced (~ three
months) yoga practitioners (8 female, 4 male). Measurements of heart rate, blood pressure,
galvanic skin resistance, and oxygen consumption were taken before and after each 45 minute
session. RNB resulted in significant increases in systolic blood pressure (9.4mm/Hg, p<0.05) and
resting oxygen consumption (43.7ml/min). Interestingly, both NB and RNB demonstrated a
significant decrease in skin resistance, indicative of an increase in sympathetic tone.
In the most recent study, Ghiya and Lee (2012) investigated the effect of an acute bout of 30
minutes of ANB in comparison to an equal period of paced breathing (PB) on HRV (low
frequency, high frequency and total power) in a young (22.3±2.9 years) mixed gender (8 male,
12 female) population. Both breathing protocols were conducted at a pace of 5 breaths per
minute. Subjects, who were not regular practitioners of yoga, participated in one familiarization
session. On a separate day participants were randomly assigned to begin with either ANB or PB.
This was followed by a five-minute washout period and the protocols were crossed over. While
there were statistically significant increases in low frequency, high frequency and total power
following the protocols, there was no significant difference between the PB and ANB groups.
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This would suggest that the pacing of the breathing exercise, independent of the type of exercise,
was responsible for the change in HRV.

Conclusion
Several methodological concerns obscure the impact of pranayama on cardiovascular
autonomic function. Firstly, the practice of pranayama is frequently used concurrently with other
aspects of yoga training (i.e. the physical training of hatha yoga and/or the mental training or
meditation commonly called dharana and/or dhyana); therefore, it is difficult to separate the
specific effects of pranayama from the larger "yogic" intervention. Secondly, virtually studies
have used young, healthy populations. Thirdly, the use of participants with knowledge of
pranayama and the expected training outcomes creates a potential skewing effect. Also, to the
authors knowledge there are no studies which have investigated either the chronic or acute effect
of pranayamic training on older populations (>60 years) or individuals with T2D.
Nevertheless, studies involving the chronic effect of pranayamic training have generally
provided consistent results. Of the four training studies that measured blood pressure, all had
significant decreases in at least one aspect of blood pressure (Ankad et al., 2011; Dhungel et al.,
2008; Srivastava et al., 2005; Veerabhadrappa et al., 2011). Similarly, five of six cited studies
found a significant reduction in resting heart rate attributable to the pranayamic intervention
(Ankad et al., 2011; Dhungel et al., 2008; Pal et al., 2004; Srivastava et al., 2005;
Veerabhadrappa et al., 2011), while one study found a significant increase (Telles et al., 1994).
In contrast, three of the acute studies found no effect on resting heart rate (Pramanik et al., 2009;
Raghuraj et al., 1998; Telles et al., 1996) and one study found a drop in resting heart rate, but it
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was not significantly different from the control group (Ghiya and Lee, 2012). Interestingly, of
the studies that assessed some direct metric of autonomic function, three found that pranayama
increased sympathetic output (Raghuraj et al., 1998; Raghuraj et al., 2008; Telles et al., 1996). A
fourth study found a significant increase in HRV following the acute pranayamic intervention,
but it was not significantly different from the control group (Ghiya and Lee, 2012). The best
evidence of an acute effect remains Pramanik et al. (2009), which demonstrated reductions in
diastolic and systolic blood pressure with pranayama which were absent with PNS blockade.
Therefore, the evidence supporting a training effect of pranayama on cardiovascular
parameters is better established than the acute effect. Nevertheless, given that there is an absence
of studies examining either the acute or chronic effect of pranayama on cardiovascular function
in T2D it is worthwhile investigating this potentially beneficial aspect of alternative therapy.
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PROJECT II
The Effect of N-Acetyl-5-Methoxytryptamine (Melatonin) Supplementation on Glycemic
Control, Lipid Metabolism, and Oxidative Stress in Type 2 Diabetes Mellitus

Substantial circumstantial evidence exists suggesting a functional relationship between
melatonin and glucose homeostasis, as well as overwhelming evidence indicating that melatonin
is a potent antioxidant. In this regard melatonin may have a significant role to play in the
treatment of T2D.

Melatonin and Glucose Homeostasis
There is an abundance of research in animal models demonstrating melatonin plays a
significant role in glucose homeostasis. However, there is a paucity of research examining this
potentially useful aspect of melatonin in human subjects. Nevertheless, the limited human
research has yielded intriguing results. For example, a recent article by Hussain et al. (2006)
examined the effect of melatonin and zinc supplementation on glucose homeostasis in subjects
with T2D (n = 46) and age-matched controls (n = 17), for a period of 90 days. The T2D subjects
were assigned to one of three groups: metformin (2550 mg/day) and placebo (group A),
metformin (2550 mg/day) and melatonin/zinc combination (10 mg/50 mg/day) (group B), or
melatonin/zinc combination (10 mg/50 mg/day) (group C). All T2D subjects were on a dietary
control program for the length of the intervention. Fasting blood samples were collected at 0, 30
and 90 days of treatment to assess fasting glucose, AlC and C-peptide. Additionally, 6 subjects
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from group A, 7 from group B and 12 from Group C underwent a post-prandial glucose
excursion (PPGE) test prior to and following 60 days of treatment, which consisted of a fasting
blood draw followed by draws at 30, 60,120, 180 and 240 minutes following a solid meal of 530
kcal. Results indicated that group B (metformin and melatonin/zinc) had a significant reduction
in FPG and A1C at 30 days (-25%, p <0.01, -17%,/? < 0.01), with a further reduction in AlCat
90 days (-26%,/? < 0.05). Group C (melatonin/zinc only) saw a reduction in FPG at 90 days (23%, p < 0.01) and reductions in A1C at 30 and 90 days (-15% and -29%, p < 0.05). In
comparison, group A (metformin and placebo) saw a more modest reduction in FPG at 90 days (9%,p < 0.01) and a reduction in A1C at 30 days of 14% (p <0.01), which was maintained at 90
days. Results of the PPGE indicate group B (metformin and melatonin/zinc) had a significant
reduction in area under the curve (AUC) from 0 to 60 days (-27.7%,p < 0.01). Overall results
indicate that the combination of melatonin and zinc, when used singly or in combination with
metformin, improved glycemic control in T2D subjects.
A study by Ha et al. (2006) investigated the effect of signaling pathways of glucose transport
in mouse skeletal muscle. Monolayers of C2C12 myoblasts were cultured for 3-7 days in order to
obtain myotubes. Cell lines were pre-treated with melatonin (1 nM and 10 nM), insulin or
luzindole (a receptor antagonist of melatonin) prior to exposure to 2-[3H]-deoxy-o-glucose for 20
minutes at room temperature. The prepared C2C12 myotube cells were processed by SDSpolyacrylamide gel electrophoresis. Phosphoinositide 3-kinase was assayed and measured.
Results demonstrated that melatonin treatment increased glucose uptake in myotubes at both
1 nM and 10 nM, increasing glucose uptake 1.9 and 1.8-fold (p < 0.01), respectively, over
controls. More importantly, myotubes that were transfected with MTNR IB-containing pcDNA
3.0 plasmid and exposed to melatonin had a 13-fold increase in glucose uptake (p < 0.01),
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compared to controls, while similarly treated myotubes exposed to insulin had only a 2-fold
increase in glucose uptake (2.1,/? < 0.01). The significance of this investigation indicates mouse
skeletal muscle myotubes had a significantly greater glucose uptake that appeared to be mediated
by melatonin receptor MTNR1B.
An intriguing study by Radziuk and Pye (2006) investigated the 24-hour glucose production
and metabolic clearance rate (MCR) of 7 subjects with T2D and 6 healthy age and BMI-matched
control subjects (CON). Subjects taking hypoglycemic agents discontinued use of medication 72
hours prior to the beginning of the investigation. Following an ad libitum breakfast at 8 am,
subjects reported to the lab for 24 hours of fasted monitoring. At 2 pm subjects began an infusion
of carbon-labeled glucose and lactate ([U-13C]glucose & [3-I4C]lactate), which continued for 24
hours. Plasma insulin, glucose, glucagon, leptin, melatonin and Cortisol were sampled according
to periods of anticipated change throughout the 24 hour period. The MCR was calculated by
analysis of non-steady state compartmental analysis. An index of gluconeogenesis was calculated
by analyzing the incorporation of carbon-labeled lactate into glucose. The concentration of
plasma glucose remained steady in CON subjects (4.9 mmol/1), with a slight decrease in the final
hours (4.4 mmol/1). The T2D subjects, while beginning at a higher glucose concentration (7.2
mmol/1) than controls, exhibited an initial decrease in plasma concentration followed by a
significant nocturnal increase (8.0 mmol/1) and a gradual decrease in the late-morning/early
afternoon hours (6.3 mmol/1). Glycemic concentrations were significantly different between T2D
and CON (p - 0.0003). The MCR curves were similar between T2D and CON; however, the
CON group exhibited a significantly greater clearance rate (1.73 ml/kg/min vs. 1.4 ml/kg/min,/?
= 0.04). Endogenous glucose production (EGP) remained near constant in the CON group (8.2
(amol/kg/min), but dipped slightly after approximately 24 hours of fasting (7.2 ^mol/kg/min).
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The T2D group, however, exhibited a steady increase from 8.2 to 11.3 jimol/kg/min throughout
the night, peaking in the early morning hours (6:30 am). Glucagon levels, while constant in both
groups, were significantly higher in the T2D (p = 0.04). The gluconeogenic index demonstrated
similar curves between groups; however, the T2D group exhibited a significant increase in
gluconeogenic activity during the late-night/early morning hours (p < 0.05). Melatonin secretion
displayed a phase-delay and attenuation in T2D subjects (p = 0.02) compared to CON and
appeared to mirror changes in EGP. Overall, results indicate a cyclicity of EGP as well as a
significant difference in glycemia between T2D and CON that appears to be driven by EGP.
An investigation by Zanquetta et al. (2003) examined the effect of calorie restriction,
pinealectomy and melatonin supplementation on glucose homeostasis and glucose transporter-4
(GLUT-4) content in male Wistar rats. Subjects underwent a pinealectomy (PO) or sham
operation (SO) 30 days prior to testing. PO subjects were further divided by daily placebo
injection (PO) or melatonin injection (50 p.g/100 g body weight) (POM). Testing procedures
commenced 30 days later and consisted of an intravenous insulin tolerance test (ivITT),
pinealectomy on SO rats and quantification of GLUT-4 gene expression (mRNA) in white
adipose tissue (WAT). Results indicated that there was a significant reduction in GLUT-4
mRNA in PO rats (~ 70%,p < 0.05). Furthermore, there was a significant increase in plasma
insulin (p < 0.05) and a significant decrease in glucose clearance in the PO rats (p < 0.05)
indicating an overall suppressive effect on glucose homeostasis in pinealectomized rats in
comparison to sham-operated controls or melatonin-supplemented pinealectomized rats.
Lima et al. (1998) examined the effect of either pinealectomy (PINX) or sham operation
(SHAM) on glucose homeostasis and GLUT-4 content and effectiveness in adipocytes at two

29

different temporal locations (8 am and 4 pm) in male Wistar rats (n = 22). Five weeks following
surgery all subjects underwent an intravenous glucose tolerance test (IVGTT) and assessment of
fasting glucose and insulin. One week post-surgery all subjects were euthanized at either 8 am or
4 pm. The epididymal fat pad was removed and processed for adipocyte isolation. The
adipocytes were assessed for insulin-stimulated 2-[3H]-deoxy-D-glucose uptake and insulin
binding. Results indicated that plasma glucose and insulin did not differ during the IVGTT when
performed at 8 am. However, when the IVGTT was administered at 4 pm, statistically significant
differences in glucose and insulin levels were present, with the PINX rats having a decreased
insulin secretion, accompanied by increased plasma glucose (p < 0.05). This difference was most
apparent in the first 20 minutes of the IVGTT, indicating a reduced P-cell response in the PINX
rats. An analysis of insulin receptor binding revealed no significant differences between PINX
and SHAM at either time point. However, one commonality between both groups was an
increase in receptor expression from 8 am to 4 pm, suggesting that differences in glucose
disposal were not mediated by insulin receptor activity and also indicating a diurnal rhythm
present in insulin receptor expression. Insulin-stimulated glucose uptake in isolated adipocytes
demonstrated a 33% decrease in responsiveness in PINX rats at both time points (p < 0.05).
Furthermore, GLUT-4 content of subjects was significantly reduced (-40%) in adipocytes of
PINX rats (p < 0.05).
A study by Mazepa et al. (2000) investigated the effect of melatonin supplementation on
muscle and liver glycogen in Wistar rats. Subjects were randomly assigned to either an exercise
or rest group. Exercised rats ran on a motorized treadmill to exhaustion. Half of the rats in each
group received intraperitoneal injections of melatonin at 0.5 or 2 mg/kg body weight.
Immediately following exercise all rats were anesthetized and liver and muscle samples were
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taken. Results indicated that melatonin supplemented exercise groups and rest groups had
significantly reduced lactate elevations when compared to the non-melatonin exercise group (p <
0.05) and non-melatonin rest group (p < 0.05). Muscle glycogen content of soleus and
gastrocnemius was significantly greater in the melatonin-supplemented exercise groups than the
exercise control group (p < 0.05). Similarly, the melatonin-supplemented rest groups both had
significantly higher muscle glycogen concentrations in comparison to the rest control group (p <
0.05). Plasma and liver P-hydroxybutyrate were significantly higher in both melatoninsupplemented exercise groups in comparison to the non-supplemented exercise group (p < 0.05),
indicating that there was an enhancement of lipid utilization in melatonin-supplemented rats
during exercise.
A recent study by Robeva et al. (2008) examined the interaction of melatonin and insulin
secretion in a group of 40 young (32.6 ± 3.17 yr) subjects with metabolic syndrome (MS) and 19
clinically healthy controls (29.3 ± 2.45 yr). Fasting blood samples were drawn to measure
glucose, insulin, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and
triglycerides (TG). Furthermore, melatonin and insulin were sampled at 11 am, 7 pm and 3 am.
Results demonstrated that there was an inverse correlation between 24 hour melatonin
production and fasting glucose (r = -0.316,p = 0.047). In subjects with MS the night/day
melatonin percentage difference correlated negatively with fasting glucose (r = -0.494, p =
0.023). There was also a weak negative correlation between percentage of day/night melatonin
difference and LDL (r = -0.367,/? = 0.025).
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Melatonin and Lipid Metabolism
An intriguing article by Nishida et al. (2002) examined the effect of 30 weeks of melatonin
supplementation on markers of lipid metabolism in male rats. Subjects were divided into three
groups: control (CON), type 2 diabetes (T2D) or diabetes and implanted melatonin (T2DM). The
melatonin implanted group received a dose of 1.1 mg/day. Non-fasting levels of plasma glucose,
insulin, leptin, TG, total cholesterol (TC), phospholipids and glutamic oxalacetic transaminase
(GOT) were measured at 0,16 and 30 weeks. An assay was performed pre and post to determine
the fatty-acid A-5 desaturase levels. Results indicated a significant decrease in plasma TG (-39%,
p < 0.05) and TC (-27%, p < 0.001) in T2DM as compared to T2D. Melatonin decreased the
level of plasma leptin at 16 (-33%, p < 0.01) and 30 (-43%,/? < 0.01) weeks in T2DM in
comparison to T2D. Melatonin had no significant effect on hyperinsulinemia at 16 weeks, but
significantly reduced insulin levels at 30 weeks (-33%, p < 0.01) in T2DM as compared to T2D.
The A-5 desaturase activity was significantly increased in the T2DM group in comparison to the
T2D group (148%,p < 0.005).
In another investigation by Nishida et al. (2003) investigators examined the effect of reduced
melatonin secretion (pinealectomy) on plasma and hepatic lipid levels in rats with (OLETF) and
without (LETO) T2D. Subjects were divided into three groups: pinealectomized rats (PO), shamoperated OLETF rats (SO) and sham-operated LETO rats (SL). Plasma leptin, insulin, glucose,
triglyceride (TG), free-fatty acid (FFA), total cholesterol (TC) and free cholesterol were
measured at 0, 16 and 30 weeks. Hepatic acetyl-Co-A synthetase activity was measured by
assay. Plasma TG levels were significantly higher in SO and PO at 0 and 30 weeks (p < 0.05,p <
0.001, respectively). Plasma free cholesterol was significantly higher in PO than SL at 30 weeks

32

(p < 0.05). Hepatic TG levels were significantly higher in PO than SO (p < 0.005) and SL (p <
0.001). Plasma leptin levels were significantly higher in SO and PO at 16 (p < 0.001) and 30 (p<
0.005) weeks, in comparison to SL.
Wolden-Hanson et al. (2000) investigated the effect of 12 weeks of melatonin
supplementation on body weight, intra-abdominal adiposity, food intake and hormone levels in
three groups of Sprague Dawley rats (young, middle-aged melatonin-supplemented and middleaged control). Physical activity was assessed by infrared beam and body composition by DEXA.
Plasma glucose, insulin, leptin, melatonin and corticosterone levels were measured by assay.
Melatonin was administered via water bottle and was approximately 1.3-1.7 (ig/h throughout the
night (10 hours). Results indicated that the melatonin-supplemented group experienced a 3% loss
of body weight while the middle-aged control group had a 3.6% increase (p < 0.0001). Core
body temperature and physical activity were both significantly higher in the melatoninsupplemented group than the age-matched control (p < 0.01 ,p< 0.05, respectively). The
melatonin group had a significant reduction in intra-abdominal fat in comparison to age-matched
controls (p < 0.05). Plasma leptin and insulin levels were significantly reduced in melatoninsupplemented rats in comparison to age-matched controls (-33% and -25%, respectively,/? <
0.05).
Kadhim et al. (2006) examined the effect of melatonin and zinc supplementation on lipid
profile using the same population and methodology as Hussain et al. (2006). Briefly, participants
with T2D (n = 46) and age-matched controls (n= 17) were randomly assigned to one of three
groups for a period of 90 days: metformin (2550 mg/day) and placebo (group A), metformin
(2550 mg/day) and melatonin/zinc combination (10 mg/50 mg/day, group B) or melatonin/zinc
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combination (10 mg/50 mg/day, group C). Fasting blood samples were collected to measure total
cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL) and low-density lipoprotein
(LDL). Urine samples were collected to measure microalbuminuria (MAU). Results indicated a
significant decline in TC for groups B and C in comparison to group A after 90 days of treatment
(p < 0.05), indicating that melatonin/zinc and melatonin/zinc in combination with metformin
lower TC more than metformin alone. Similarly, there was a significant reduction in TG in
groups B and C in comparison to group A (p< 0.05), indicating that melatonin/zinc and
melatonin/zinc in combination with metformin lower TG more than metformin alone. Groups B
and C also significantly increased HDL levels in comparison to group A (p < 0.01). LDL levels
were significantly reduced in groups B and C at 30 and 90 days in comparison to group A ( p <
0.05) and significantly reduced in comparison to baseline values. Likewise, groups B and C also
experienced a significant decline in MAU in comparison to baseline values and group A ( p <
0.05).

Melatonin and Antioxidant Capability
Oxidative stress can be broadly described as an imbalance between reactive oxygen species
(ROS) production and the cellular ability to reduce these potentially harmful substances through
antioxidant defenses. At physiological levels ROS are important cellular signaling molecules and
a normal byproduct of cellular metabolism. Under optimal conditions ROS molecules are rigidly
controlled by endogenous antioxidant defenses, effectively nullifying any deleterious effect. An
oxidative imbalance, which is a direct result of hyperglycemia, will result in cellular damage and
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is a significant contributing factor to the pathophysiology of T2D (Brownlee, 2001; Ceriello and
Testa, 2009).
While there is a strong theoretical background advocating the use of conventional antioxidant
therapy to ameliorate oxidative stress, studies using supplemental vitamins C, E and betacarotene have yielded disappointing results (Beckman et al., 2003). In fact, two meta-analyses
that have investigated the effect of antioxidant status on the prevention of cardiovascular disease
and all-cause mortality found no relationship with the cardiovascular death rate (Vivekananthan
et al., 2003). Taken in entirety the evidence supporting conventional antioxidants translating into
improved health outcomes is equivocal.
Conventional antioxidants, however, represent only a small portion of a biologically active
class of compounds that inhibit oxidation. Given the lackluster performance of conventional
antioxidants in addressing health-related outcomes induced by oxidative stress it has been
suggested that a "new antioxidant" approach to oxidative stress should focus on increasing
intracellular antioxidant defenses and controlling free radical formation at its source (Ceriello
and Testa, 2009).
Under optimal conditions conventional antioxidants quench oxidants as they are formed.
However, T2D represents a disease state in which there is an imbalance between antioxidative
resources and oxidant production that results in a state of oxidative stress. The "holy grail" of
antioxidants would be capable of directly scavenging free radicals, but more importantly, it
would also be capable of: a) stimulating antioxidative enzymes, b) directly promoting
glutathione synthesis, and c) reducing production of free radicals in the mitochondria. Evidence
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from animal and human models suggests that melatonin is capable of achieving these results
(Reiter et al., 2007).
An investigation by Paskaloglu, Sener and Ayanoglu-Dulger (2004) examined the effect of
exogenous melatonin supplementation on glutathione synthesis and diabetes-induced changes in
rat aorta and corpus cavernosum. Twenty four male Wistar rats were divided into one of three
groups: control group (CON), diabetes-induced group (DM) or melatonin treated (MEL). The
DM group was further divided into four subgroups: melatonin treated (10 mg/kg/day), insulin
treated (6 U/kg/day), insulin and melatonin treated, or no treatment. At eight weeks the rats were
euthanized. The corpus cavernosum and aorta were removed and analyzed. Excised tissues were
analyzed for isometric contraction using a force-displacement transducer. Glutathione was
assessed by spectrophotometry and malondialdehyde was assessed by assay. Smooth muscle
contractility of the aorta was significantly reduced in the DM group compared to CON (p <
0.001). Treatment of insulin, melatonin or both in the diabetes-induced group significantly
improved contractility. Levels of malondialdehyde, a by-product of lipid peroxidation, were
significantly higher in diabetes-induced rats than in CON {p < 0.001). Melatonin or the
melatonin/insulin combination significantly reduced malondialdehyde levels in diabetes-induced
rats in comparison to the diabetes control group (p < 0.001). Glutathione levels were decreased
in the DM group when compared to the CON group (p < 0.001). Melatonin or melatonin/insulin
significantly increased glutathione synthesis in comparison to the diabetes control group (p <
0.001).
An article by Chang et al. (2000) investigated the influence of melatonin supplementation on
oxidative damage. Sixty five male Wistar rats were divided into four groups: untreated control
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(group 1), injected control (group 2), melatonin supplemented (5 mg/kg) (group 3) and melatonin
supplemented (100 mg/kg) (group 4). Sixty of the rats underwent a hypoglossal nerve (HN)
transection, while five of the untreated controls had a sham operation in which the HN was
exposed, but not transected. Subjects were processed at 3, 7, 14, 21 or 30 days. NADPH-d and
nitric oxide synthase (NOS) were quantified from tissue sections. In group 1 NADPH-d and
NOS reactivity were increased at 3 (1.71%), 7 (37.6%) and 14 (65.7%) days, before beginning a
gradual decline. Group 3 was significantly decreased in comparison to group 1 at days 7 (30.5%
vs. 37.6%,p < 0.05), 14 (48.6% vs. 65.1%,p < 0.05), 21 (43.1% vs. 36.9%,/? < 0.05) and 30
(19.9% vs. 15.7%) days. Group 4 experienced even greater reductions in comparison to group 1
at days 7 (37.6% vs. 21.2%,/? < 0.05), 14 (65.7% vs. 31.8%,/? < 0.05), 21 (43.1% vs. 23.6%,/? <
0.05) and 30 days (19.9% vs. 12.3%), indicating an inverse dose-response relationship between
level of oxidative stress and melatonin dose.

Toxicology of Exogenous Melatonin
A study by Seabra et al. (2000) investigated the toxieological effects of melatonin
supplementation over a period of five weeks. Forty healthy male volunteers (25-55 years) were
assigned to either control (n = 10) or melatonin group (n - 30). An initial baseline visit included
polysomnography testing (PSG), the Epworth Somnolence Scale (ESS), plasma melatonin levels
and clinical lab exams, including blood cell count, albumin, glucose, triglycerides, total
cholesterol, HDL, LDL, very low-density lipoprotein (VLDL), urea, creatinine thyroid
stimulating hormone (TSH), T3, T4, Cortisol and melatonin levels. All subjects were further
required to keep a sleep diary. Melatonin (10 mg) and/or placebo pills were provided with
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instructions to ingest pill one hour before bedtime. Three site visits, each spaced seven days
apart, followed, in which subjects filled out side effects (SE) questionnaires and underwent blood
sampling, PSG and ESS testing. The intervention period was 28 days. A fifth round of testing
occurred seven days post-intervention. There were no significant differences between groups for
any parameter in the clinical exam or biochemical analysis. The most common side effects were
somnolence (n = 17) and headache (n = 14). The placebo had a rate of SE of 83.3% and the
melatonin group 60%, with no significant difference between groups. There were no significant
adverse events reported.
Jan et al. (2000) investigated the effective dose of controlled release (CR) and fast release
(FR) melatonin necessary to treat chronic sleep-wake cycle disorders in 42 multi-disabled
children (4-21 yr). An initial randomized, double-blind crossover design involving 16 children
currently taking melatonin for three months was implemented. The subjects received either FR or
CR at varying doses (2-20 mg) for a period 11 days, after which the type of melatonin was
crossed over for an additional 11 days. Following the initial 22 day period all children received
the CR melatonin for several weeks; the parents were encouraged to alter the dose in order to
find the minimal most effective dosage. A follow-up study was conducted with 42 children that
were currently taking melatonin (avg. duration of treatment 2.2 years). The subjects received CR,
FR or a combination thereof for an average duration of 2.8 years. No significant adverse effects
were reported.
Melatonin has been extensively studied in humans at dosages ranging from 5 mg up to 20
grams per day (Kedziora-Kornatowska et al., 2007; Lissoni et al., 1997) with no serious adverse
events reported and is widely regarded as a nontoxic and benign substance (Reiter et al., 2009).
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Two recent meta-analyses', which examined 27 studies with a cumulative population of 873
subjects, concluded that melatonin was safe within the investigated dosages (0.5 - lOmg) and
timeframes (1-90 days) and there were no significant differences in reported side effects
between melatonin and placebo. The most commonly reported side-effects of melatonin
supplementation are nausea, headache, dizziness and drowsiness (Buscemi et al., 2005; Buscemi
et al., 2006).

Conclusion
Recent articles suggest that glycemic control may be related to melatonin secretion (Radziuk
and Pye, 2006; Robeva et al., 2008). Interestingly, melatonin secretion is diminished in T2D
(Peschke et al., 2007), which is characterized by hyperglycemia, as well as being negatively
correlated with aging (Claustrat et al., 2005; Lunenfeld et al., 2001). Similarly, there also exists a
relationship between aging and insulin resistance, with advancing age being positively correlated
with increasing insulin resistance (Fujita et al., 2007). It has been demonstrated in animal models
that the suppression of melatonin through pinealectomy has a significant negative impact upon
glucose homeostasis by decreasing insulin sensitivity, as well as reducing GLUT-4 content and
insulin-stimulated glucose uptake in rats (Zanquetta et al., 2003; Lima et al., 1998).
Furthermore, melatonin suppression through pinealectomy also appears to have a deleterious
effect upon plasma and hepatic triglycerides and plasma cholesterol (Nishida et al., 2003).
Melatonin supplementation, however, has demonstrated significant improvements in
glycemic control in subjects with T2D (Hussain et al., 2006), has increased glucose uptake in in
vitro skeletal muscle (Ha et al., 2006), and has shown a glycogen sparing effect in skeletal

39

muscle (Mazepa et al., 2000). Its supplementation is also associated with up-regulation of
GLUT-4 content (Zanquetta et al., 2003; Mazepa et al., 2000).
Perhaps as importantly, there also appears to be a relationship between melatonin and lipid
metabolism. Melatonin supplementation has demonstrated increased lipid metabolism during
exercise (Mazepa et al., 2000) as well as decreasing abdominal adiposity (Wolden-Hanson et al.,
2000) in rats. Likewise, melatonin has shown significant improvements for total cholesterol,
triglycerides and LDL cholesterol (Kadhim et al., 2006), while reducing long-term
hyperinsulinemia and increasing hepatic lipid metabolism (Nishida et al., 2002).
T2D contributes to a state of hyperglycemia-induced oxidative stress that increases
endothelial dysfunction (Paskaloglu, Sener and Ayanoglu-Dulger, 2004) and microvascular and
macrovascular damage (CDC, 2011; ADA, 2007). Melatonin, however, is a potent antioxidant
(Korkmaz et al., 2009; Tan et al., 1993) and appears to have the capability to ameliorate many of
the associated deleterious processes by increasing antioxidant defense (Paskaloglu, Sener and
Ayanoglu-Dulger, 2004; Reiter et al., 1995). Furthermore, melatonin supplementation has been
found to be nontoxic at physiologic and pharmacologic levels in both humans and animals
(Hussain et al., 2006; Jan et al., 2000; Seabra et al., 2000; Nishida et al., 2002).
There is, however, a relative dearth of research investigating the effect of exogenous
melatonin on glucose homeostasis, lipid metabolism and oxidative stress in humans. This gap in
the literature provides a compelling reason to undertake an investigation into the role of
supplemental melatonin.
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PROJECT III
The Effects of Walking vs. Table Tennis on Postprandial Glycemia, Heart Rate Variability,
and Mood in Type 2 Diabetes

Postprandial Glycemia
The primary goal for the treatment of T2D is the strict control of blood glucose levels. Several
clinical trials have found that reductions in AlC, a long-term marker of glycemic control, are
associated with decreased risk of vascular complications (Shichiri et al., 2000; UKPDS, 1998).
This is significant as micro- and macrovascular complications represent the primary source of
mortality and morbidity in diabetes (Fowler, 2008). The American Diabetes Association
recognizes an AlC level of 6.5% as a threshold of diagnosis, as well as being associated with an
increased risk of retinopathy (ADA, 2012). However, several recent investigations have
indicated that control of postprandial glycemia may play a more prominent role in AlC
maintenance than simply controlling fasting blood glucose (Shichiri et al., 2000; Woerle et al.,
2007).
Woerle et al. (2007) investigated the effect of a forced, titrated glycemic treatment program
on 164 T2D individuals with poor glycemic control (A1C>7.5%). Subjects participated in 10.5
hours of diabetes training and optimal therapy modification was overseen by a physician.
Participants self-monitored blood glucose levels seven times per day; three preprandial
measurements were taken at 7 am, 1 pm and 7 pm, three postprandial measurements were taken
90 minutes after each of three meals, and a final measurement was taken at 11 pm. AlC levels
were measured at baseline and following the three month intensive glycemic control
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intervention. Goals for the intervention included achieving a fasting glucose level <100mg/dL
and a 90 minute postprandial glucose level <140mg/dL. At the conclusion of the intervention
subjects were stratified into two groups, those that achieved an A1C < 7% and those that
remained > 7%. There was a significant overall reduction in fasting plasma glucose levels in both
groups (-174 mg/dL to ~117 mg/dL). However, the <7% group had significantly lower average
postprandial (-27 mg/dL, p<0.001) and daylong glucose levels (-24 mg/dL, p<0.001) than the
>7% group. Within the <7% group only 64% achieved a fasting glucose level <100 mg/dL;
however, 94% of those that achieved a postprandial glucose level <140 mg/dL had an A1C level
<7%. The results of this investigation demonstrate that postprandial glycemia contributes more
than fasting glucose levels to A1C.
The role of postprandial glycemic spikes in complications of T2D is multifactorial. For
example, a recent study by Tobin et al. (2011) investigated the effect of a 75 gram dose of
glucose on postprandial microcirculation in eight male subjects with T2D and eight age- and
BMI-matched normoglycemic subjects. Ultrasound was used to measure blood flow of the
subcutaneous abdominal adipose tissue and the musculature of the forearm (brachioradialis).
Ultrasound measurements were taken at 60,120 and 180 minutes following the glucose load.
Results demonstrated that the T2D group had no change in blood flow to adipose tissue at any
time point. In contrast, the age- and BMI-matched control group realized a significant increase in
blood flow to adipose tissue at 60 and 120 minutes following glucose ingestion. The T2D group
demonstrated significantly higher plasma glucose levels than the control group at all time points.
In the aftermath of meal ingestion, an increase in blood flow to adipose tissue aids in regulating
plasma macronutrient levels as excess glucose and lipids may be stored and removed from
circulation. However, in this investigation, individuals with T2D demonstrated a blunted
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vascular response following glucose ingestion. In the short-term this reduction in circulation
could be a contributing factor to postprandial glycemic spikes. The long-term consequences,
however, could be much more significant and could potentially include increased incidence of
micro- and macrovascular disease.
The acute effect of a bout of aerobic exercise has been shown to lower blood sugar levels in
T2D for 24 to 72 hours (ACSM/ADA, 2010). The timing of an exercise intervention, however,
may have an important impact of postprandial glycemic spikes in individuals with T2D.
Recently, Colberg et al. (2009) compared the effect of 20 minutes of low-to-moderate intensity
exercise (-40% of heart rate reserve) undertaken before and after a standardized meal of
approximately 400 kilocalories. Two exercise trials, before and after dinner (PRE and POST,
respectively), and one non-exercise control trial (CON) were undertaken in random order by 12
older (61.4±2.7years) individuals with uncomplicated T2D. Blood glucose was measured via an
intravenous catheter at 30 minutes intervals during the four-hour intervention. The change in
plasma glucose at 90 minutes, immediately following the cessation of exercise, was significantly
lower in the POST group (-0.41±0.34 mmol/L) compared to the Pre (1.83±0.66) and CON
(0.73±0.56) groups. These results indicated low-to-moderate intensity postprandial exercise may
be more effective than preprandial exercise at controlling a postprandial glycemic spike.
Similarly, Poirier et al. (2000) investigated the effect of a bout of moderate-to-vigorous
aerobic exercise on plasma glucose levels in 10 sedentary males with T2D (54±5years). Subjects
participated in two randomly assigned trials during which they exercised for 60 minutes at 60%
ofV02peak. The trials consisted of exercise in the fasted state (CON) or following a 395-calorie
standardized breakfast meal (BF). Plasma glucose levels were measured at 15 minute intervals
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throughout the exercise bout and up to 30 minutes post-exercise. Plasma glucose levels were
significantly reduced at the end of 60 minutes of exercise in CON, however, plasma glucose
returned to baseline levels within 15 minutes. In contrast, in the BF trial 60 minutes of exercise
following a breakfast meal resulted in a significant plasma glucose reduction immediately
following exercise (60 minutes) and during recovery (at 75 and 90 minutes, respectively). These
results indicate that 60 minutes of moderate-to-vigorous exercise had a significantly greater
impact on plasma glucose levels when in a postprandial state than in a fasted state.

Heart Rate Variability
Heart rate variability (HRV) is measured by the time oscillation between successive heart
beats and represents the inputs of autonomic control over the cardiac cycle. In the absence of
external stimuli the intrinsic heart rate is > 100 bpm (Jose et al., 1970). This baseline value,
however, is in a constant flux created by a balance between inputs from the sympathetic and
parasympathetic branches of the autonomic nervous system. These two autonomic inputs,
collectively termed sympathovagal balance, act in a coordinated manner and represent the hearts
ability to adapt to changing stimuli (Acharya et al., 2006).
HRV measurements are categorized as time, frequency or geometric domain, with time and
frequency domain the most commonly cited measurements in the literature (Task Force, 1996).
This measurement reflects the variability within the cardiac cycle or, more succinctly, the
balance between sympathetic and parasympathetic influence and has demonstrated an ability to
provide important information about autonomic modulation (Task Force, 1996). T2D is
associated with a reduction of heart rate variability (Singh et al., 2000). Reduced HRV has also
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been associated with increasing carotid artery atherosclerosis and may be an early predictor of
macrovascular disease in T2D (Gottsater et al., 2006).
Autonomic nervous system damage, termed autonomic neuropathy (AN), is a common
complication of T2D and can affect any organ of the body (Vinik and Erbas, 2001). AN is a
serious neurological deficit and the mortality rate of those with symptomatic AN is 25-50%
within 5-10 years (Ewing, Boland and Neilson, 1991; Rathman et al., 1993). Damage to the
vagal component of the autonomic nervous system appear early in T2D, contribute to the
imbalance between sympathetic and parasympathetic inputs (sympathovagal balance), and
manifest as diastolic dysfunction (Poirier et al., 2003). Importantly, however, the onset of
cardiovascular autonomic dysfunction may appear prior to diagnosis of T2D. In a study by
Laitinen et al. (2011) researchers investigated the prevalence of cardiovascular autonomic
dysfunction among 177 older (62±7years) overweight or obese (BMI 29.6±4.5kg/m )
participants enrolled in the Finnish Diabetes Prevention Study. Parasympathetic dysfunction was
assessed via the E/I ratio during three to four cycles of deep breathing and sympathetic
dysfunction was measured by the decrease of systolic blood pressure > 20 mm/Hg during
standing. Parasympathetic dysfunction comprised 25% of the subject population, while
sympathetic dysfunction was only 6%.
Exercise training, however, has demonstrated an important ability to improve HRV in T2D. A
study by Zoppini et al. (2007) investigated the effect of a six-month aerobic training program on
HRV in 12 older (65.7±5.6years) individuals with T2D. Seven males and five females
participated in a twice weekly program of moderate-to-vigorous exercise at 50 to 70% of heart
rate reserve. There were no significant changes in measurements of HRV during 10 minutes of
supine rest. There was, however, a significant increase in high frequency power (vagal
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modulation), a significant decrease in low frequency power, and a significant improvement in
sympathovagal balance with measurements taken during a 10-minute period of standing. These
results indicate a significant shift toward vagal improvement in individuals with T2D following
an aerobic training program.
Furthermore, Figueroa et al. (2007) demonstrated improvements in HRV in obese women
with and without T2D following a 16-week training program. Prior to the beginning of the
training program, eight females with T2D (50±lyear) and 12 obese females (48±2years) without
T2D underwent a maximal oxygen consumption (V02max) test. On a separate day resting
measurements of HRV were taken in the supine position for five minutes. Immediately thereafter
each participant performed a treadmill exercise session at 65% of VC^max- Approximately 20
minutes after the cessation of exercise another five minute recording was taken in the supine
position. Measurements were repeated at the end of the 16-week, thrice-weekly training
program. Similar to Zoppini et al. (2007), there were no significant changes in HRV taken at rest
following the training intervention. However, measurements taken 20 minutes after an acute bout
of exercise at 65% of VC^max, following the training intervention, demonstrated increases in high
frequency power, low frequency power and baroreflex sensitivity.

Affective Response
Exercise is a core recommendation for the treatment and prevention of T2D (ACSM/ADA,
2010). However, it has been reported that exercise levels among individuals with T2D fall far
below the recommended levels (Nelson et al., 2002). For example, Morrato et al. (2007) reported
that among a sample of 23,283 U.S. adults, nearly 60% of individuals without diabetes engaged
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in 30 minutes or more of moderate-to-vigorous exercise at least three times per week. Among
individuals with diabetes, however, only 38.5% reported regular exercise. Interestingly, there
was an inverse relationship between the number of diabetes risk factors and likelihood of
engaging in regular moderate-to-vigorous exercise.
The affective response to exercise is an important predictor of exercise adherence. An
investigation by Williams et al. (2008) examined the association between affective response to a
single bout of exercise and future exercise participation over an unsupervised 12-month followup period. At baseline 37 older (43.9±8.6 years), sedentary participants filled out a Physical
Activity Recall (PAR) questionnaire, an interviewer-administered instrument that measures
physical activity participation within the prior seven days. Along with the PAR, the Feeling
Scale (FS), a single-item 11-point dimensional scale that measures affect, was also administered
prior to undergoing a single bout of graded exercise, which terminated at 85% of age-predicted
maximal heart rate. The exercise test, the Balke treadmill protocol, began at 3 mph and increased
grade by 2.5% in two-minute intervals. The FS was administered at the end of each interval and
the PAR and FS were administered again at six and 12 months. Results indicated there was a
positive correlation between affective response on the FS during the single bout of exercise and
subsequent minutes of physical activity participation at six and 12 months of follow-up.

Conclusion
Exercise is a proven and widely prescribed form of treatment for T2D (ACSM/ADA, 2010).
However, individuals with T2D are less likely to participate in exercise (Morrato et al., 2007).
Postprandial glycemia may play a disproportionately large role in glycemic control (Woerle et
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al., 2007). Exercise is known to improve glycemia, however, and may be more impactful when
undertake following a meal (Colberg et al., 2009). Affective response to exercise is predictive of
exercise adherence (Williams et al., 2008). Damage to the autonomic nervous system occurs
early and extensively in T2D (Vinik and Erbas, 2001). HRV is an accepted, non-invasive method
of assessing autonomic modulation (Task force, 1996). Furthermore, exercise has demonstrated a
significant ability to improve parameters of HRV in T2D (Figueroa et al., 2007; Zoppini et al.,
2007). Therefore, a more recreational form of exercise, which improves affective response, may
improve exercise adherence and positively impact postprandial glycemia and autonomic
function.
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CHAPTER III
PROJECT I
The Acute Effect of Short-Term Breathing Exercises on Sympathovagal Balance in Type 2
Diabetes

INTRODUCTION
The autonomic nervous system (ANS), via the sympathetic and parasympathetic branches, act
in a coordinated manner to maintain cardiovascular homeostasis. Heart rate variability (HRV)
reflects the beat-to-beat fluctuations, as measured in milliseconds, of the cardiac cycle that are
reflective of the dynamic response of the cardiovascular control systems to physiological
perturbations. Under resting conditions HRV is a measure of the underlying tone or balance
between sympathetic and vagal inputs, with high variability representing an enhanced adaptive
ability and low variability reflecting a diminished adaptive ability.
While type 2 diabetes (T2D) is associated with a total reduction of HRV decrements of
parasympathetic activity are independently associated with diastolic dysfunction (Poirier et al.,
2003) and contribute to the high incidence of cardiovascular disorders in T2D. Importantly,
however, decrements in sympathetic activity are also present in T2D and may decrease the
threshold for ventricular fibrillation and predispose an individual with T2D to ventricular
tachyarrythmias (Acharya et al., 2006). Conversely, increased tone of the parasympathetic
nervous system (PNS) may be protective against sudden cardiac death (Task Force, 1996). As
such, HRV represents a simple and non-invasive tool which is useful for understanding the status
of the autonomic nervous system in T2D (Acharya et al., 2006).
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Damage to the autonomic nervous system is a common complication of T2D, which can
result in autonomic neuropathy (AN) and have a deleterious effect on any organ of the body
(Vinik and Erbas, 2001). AN is a serious neurological deficit and the mortality rate of those with
symptomatic AN is 25-50% within 5-10 years (Ewing, Boland and Neilson, 1991; Rathman et
al., 1993). Furthermore, the onset of AN occurs early in the pathology of T2D and is frequently
identifiable within the first year after diagnosis (Pfeiffer et al., 1984).
A common sign of AN is a reduction in HRV, which may be an early predictor of
macrovascular disease in T2D (Gottsater et al., 2006). In fact, there are detectable deficits in
HRV prior to the onset of T2D in the presence of impaired fasting glucose (Singh et al., 2000).
Reductions of HRV are also associated with duration of T2D and, significantly, there is a
correlation between decreasing HRV and increasing carotid artery atherosclerosis in T2D
(Gottsater et al., 2006).
Yoga is an ancient vedic science composed of eight distinct disciplines. The modern practice
of yoga, however, focuses on the three disciplines of hatha yoga (physical postures), pranayama
(breathing exercises), and dhyana (meditation). Yogic breathing exercises have independently
demonstrated improvements across a diverse variety of ailments and diseases, including
hypertension (Dhungel et al., 2008), irritable bowel syndrome (Taneja et al., 2004) and
pulmonary function (Malhotra et al., 2002). Pranayama is associated with improved autonomic
tone, specifically increased PNS activity (Jerath et al., 2006). Many studies have demonstrated
significant short-term improvements in cardiovascular variables with pranayama that may be
attributable to improvements in autonomic tone and/or improvements in sympathovagal balance
(Dhungel et al., 2008; Srivastava et al., 2005; Pal et al., 2004).
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There is, however, only a limited amount of data investigating the effect of pranayama on
HRV and sympathovagal balance. Furthermore, to the author's knowledge this is the first study
specifically investigating the effect of pranayama on HRV in T2D. Pranayama represents a
simple, inexpensive and non-invasive tool that may play a role in improving HRV and, more
specifically, parasympathetic drive. Therefore, the purpose of this study was to determine the
extent to which a commonly employed yogic breathing technique (alternate nostril breathing, or
ANB) affects HRV in individuals with T2D.

METHODS
Subjects
Twelve subjects with uncomplicated T2D (7 female, 5 male; 54.9±7.4 years) and 14
normoglycemic subjects (12 female, 2 male; 54.7±6.8 years) participated in this investigation.
The average length of diagnosis within the T2D group was 8.4±6.2 years. All individuals with
T2D were treated with oral anti-hyperglycemic drugs and/or diet and exercise. All subjects were
pre-screened via a health screening questionnaire to determine eligibility. Exclusionary criteria
included congested nasal passages (i.e., common cold or allergies), a deviated septum,
congestive heart failure, myocardial infarction, arrhythmia or any cardiovascular event in the
previous year, liver disease, kidney disease or pulmonary disease. The study was approved by
the Old Dominion University Institutional Review Board and all subjects provided signed
informed consent.
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Protocol
Subjects were asked to refrain from eating within three hours of testing or consuming any
caffeine-containing products on the morning of the testing day. Subjects were fitted with a
Bioharness (Zephyr Technology Corp., Annapolis, MD). After pre-moistening the electrodes on
the Bioharness, which is similar to a standard heart rate monitor and consists of a single Velcroadjusted strap, it was placed against the skin, under clothing, at the level of the sternum.
Subjects were positioned in a comfortable chair with the feet flat on the ground prior to
receiving detailed verbal instructions regarding the breathing protocol. A laptop computer
displaying a breath-pacing program was positioned at eye level to provide both auditory and
visual cues for breath pacing (E-Z Air Plus, Thought Technology Ltd., West Chazy, NY). For the
ANB portion of the protocol the subjects were instructed to use the contralateral hand to depress
and seal off the assigned nostril by placing a single finger (the ring finger) over the nasal
vestibule and depressing the tip of the finger until the cessation of air flow was confirmed
(Saraswati, 2008). Briefly, the breathing protocol consisted of: 5 minutes of spontaneous
breathing (non-paced) (Baseline 1), 2 minutes of spontaneous breathing standing in place (Stand
1), 5 minutes of paced breathing at a rate of 6 breaths per minutes (Baseline 2), 10 minutes of
randomly assigned uni-nostril breathing (left nostril breathing (LNB), or right nostril breathing
(RNB)), 5 minutes of paced breathing (Baseline3), 10 minutes of uni-nostril breathing (using the
opposite nostril) (ANB2), and finally 2 minutes of paced breathing while standing in place. The
paced breathing portion of the protocol was adjusted so each inhale was 4 seconds and each
exhale was 6 seconds in duration. The total breathing protocol lasted 39 minutes. HRV
measurements are presented as individual epochs of time, as well as an "overall" epoch, which
encompasses the entire 39 minute protocol.
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Heart Rate Variability
HRV data were recorded on a Bioharness collecting at a sampling rate of 250 Hz. The data
were then exported as a text file to the HRV analysis software program Kubios HRV 2.0
(Biosignal Analysis and Medical Imaging Group, Department of Physics, University of Kuopio,
Finland). Data was visually inspected on a computer monitor to minimize presence of artifact.
Detrending of raw data was performed according to Tarvainen et al. (2002) and power frequency
analysis was performed using a fast Fourier transform with Welch's periodogram (256s window
with 50% overlap). The following time and frequency domain indices were calculated from the
R-to-R intervals: standard deviation of the normal-to-normal RR intervals (SDNN), the square
root of the mean squared differences of successive RR intervals (RMSSD) and total spectral
power (TP).

Statistics
Data analyses were performed with PASW 17.0 (SPSS, Chicago, IL). All data, except
instantaneous heart rate (HR) were logarithmically transformed to induce normality. Within
group comparisons were analyzed using ANOVA with repeated measures on 8 time points
(Baseline 1, Stand 1, Baseline 2, ANB 1, Baseline 3, ANB 2, Stand 2 and Overall). Between
group comparisons were analyzed using independent samples t-test.
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RESULTS

Between Groups
Baseline RMSSD in the T2D group was significantly lower than CON (p=0.03). Baseline 2
SDNN and RMSSD were significantly lower in T2D compared to CON (p=0.01 and p=0.02,
respectively). LNB SDNN, RMSSD and TP were significantly lower in T2D compared to CON
(p=0.001, p=0.002 and p=0.001, respectively) (Figure III.1). Baseline 2 SDNN and RMSSD
were significantly lower in T2D than CON (p=0.003 and p=0.002, respectively). RNB SDNN,
RMSSD and TP were significantly lower in T2D compared to CON (p=0.01, p=0.004 and
p=0.01, respectively). Baseline 3 measurements of SDNN and RMSSD were significantly lower
in the T2D group (p<0.05) (Figure III.3). Last Stand SDNN, RMSSD and TP were significantly
lower in T2D than in CON (p=0.02, p=0.007 and p=0.02, respectively). Mean HR during Last
Stand was significantly higher in the T2D group (7.7bpm, p<0.05) (Figure III.2). Overall SDNN,
RMSSD and TP were significantly lower in T2D than in CON (p=0.009, p=0.005 and p=0.02,
respectively). See Figures III.4, III.5 and III.6 for full protocol comparison of SDNN, RMSSD
and TP.

Within Groups
In the T2D group the LNB protocol resulted in a significantly lower mean heart rate (1.2bpm, p=.014) in comparison to the overall protocol measures (Figure III.7). The LNB also
resulted in a significant decrease in TP compared to Last Stand (-0.15, p<0.05). There were no
other significant interactions within the CON or T2D groups.
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DISCUSSION
Our findings indicate that two acute bouts of 10 minutes of ANB had no effect on HRV
within the T2D group or an age-matched normoglycemic group. Comparisons between groups,
however, demonstrated significant reductions in nearly all measures of HRV in the T2D
individuals compared to the CON group.
The intrinsic control of heart rate is regulated by the sino-atrial (SA) node. In the absence of
outside neurohumoral inputs the SA node maintains a rhythm of approximately 106 beats per
minute (bpm) and displays an age-related decline (Jose et al., 1970). Actual resting heart rate,
however, is controlled by the counter-balancing of sympathetic and parasympathetic (vagal)
inputs to the SA node. While these autonomic inputs occur simultaneously, given that a normal
resting heart rate is < 70 bpm (Hoffman, 2006), the vagal influence predominates. Therefore,
resting heart rate may be used as an index of autonomic tone (Lahiri et al., 2008). In fact, a
higher resting heart rate in middle age is predictive of onset of T2D later in life (Carnethon et al.,
2008). An increased resting heart rate is also associated with cardiac autonomic neuropathy
(CAN) (Ewing and Clarke, 1986). Increased resting heart rate in individuals with T2D is also
predictive of increased mortality and cardiovascular complications (Hillis et al., 2012).
Significantly, HRV is also inversely associated with plasma glucose levels in T2D, as well as in
prediabetes (Singh et al., 2000).
T2D and prediabetes are both associated with a reduction in HRV (Singh et al., 2000), as was
confirmed in the present investigation. Parasympathetic damage occurs earlier in the pathology
of T2D than sympathetic damage, results in sympathovagal imbalance, which manifests as
diastolic dysfunction, and contributes to the high incidence of cardiovascular disorders in T2D
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(Poirier et al., 2003). This occurs, in part, because sympathetic activity decreases the fibrillation
threshold and may predispose an individual to ventricular fibrillation, while vagal activity
increases the threshold and has a protective effect against malignant ventricular tachyarrythmias
(Acharya et al., 2006).
Numerous studies have found a significant training effect of yogic breathing exercises upon
vagal drive and sympathovagal balance in healthy populations. For example, Udupa et al. (2003)
demonstrated that three months of pranayama training (20 minutes per day, five days per week)
significantly lowered resting heart rate among adolescent boys in comparison to a control group.
However, the pranayama training involved a combination of four different yogic breathing
exercises and did not involve any direct measures of HRV. More recently, Dhungel et al. (2008)
demonstrated that four weeks of ANB conducted daily in 15-minute sessions significantly
reduced resting heart rate, as well as respiratory rate and diastolic blood pressure. Similar to
other studies with significant effects, however, Dhungel et al. used healthy, young (24.7 years)
predominantly male subjects. In a more recent investigation, Ankad et al. (2011) showed that 15
days of pranayama training significantly lowered resting heart, systolic and diastolic blood
pressure and mean arterial pressure in a group of 50 individuals with a diverse age range (20-60
years, mean of 38.6±8.9) and evenly matched gender (24 male, 26 female). Complicating the
interpretation of this study, however, was the fact that the daily intervention also included several
other components such as meditation.
While several studies have demonstrated a significant training effect of pranayama on
autonomic function, fewer have demonstrated an acute effect. Additionally, results have been
equivocal and inconsistent. For example, an investigation of the acute effect of a single bout of
15 minutes of ANB in young, healthy male subjects found no significant effect upon HRV
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(Raghuraj et al., 1998). In contrast Shannahoff-Khalsa and Kennedy (1993) found that a single
bout of ANB conducted for 15 minutes significantly altered heart rate, with LNB decreasing and
RNB increasing resting heart rate. The subjects in this investigation, while older (45.1 years),
were also previously experienced in yogic breathing exercises. Raghuraj and Telles (2008) found
mixed results in a study investigating the acute effect of 30 minutes of ANB breathing on HRV
in young, healthy male subjects. However, inconsistencies within the design of that study make
interpretation of this investigation problematic. Perhaps the best evidence linking the acute effect
of yogic breathing exercises to autonomic function was a study by Pramanik et al. (2009). Using
a pharmaceutical blockade of parasympathetic stimulation researchers compared the effect of
five minutes of slow pranayama on resting heart rate and blood pressure in 49 participants (10
subjects received the PNS blockade 30 minutes prior to pranayama). Results indicated significant
reductions in diastolic and systolic blood pressure in the group without PNS blockade, and no
change within the PNS blockade group.
The inconsistency within acute studies, while intriguing, may be based upon the potential
mechanism through which pranayama exerts it autonomic-modifying effect. While there is no
clear consensus on how pranayama works it has been hypothesized that the autonomic nervous
system is "functionally reset" through stimulation of slowly adapting pulmonary stretch
receptors (SAR) and hyperpolarization of fibroblasts located within connective tissue found
within the lungs (Jerath et al., 2006). Located within smooth muscle of the airways, the SARs, a
class of pulmonary vagal receptor (Wang and Zhang, 2003), continuously gauge tension within
the elastic components of the tracheobronchial tree. The structure and function of SARs remains
controversial; however, they have been found to play a role in systemic vascular tone and heart
rate (Jerath et al., 2001), potentially explaining the greater effect noted in training studies as
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opposed to acute studies. Further clarification of the interplay between the autonomic nervous
system and afferent lung receptors will be needed before the potential mechanism of action
underlying pranayama may be elucidated.
The present investigation diverges from previous ones in several important ways. Firstly, the
population within this investigation was substantially older. Secondly, no studies have previously
investigated the effect of pranayama in T2D. The present investigation found no significant
effect of ANB on measurements of HRV in an older (54.7 years), but normoglycemic,
population or an age-matched population of individuals with T2D. It is worth noting, however,
that this investigation adds to the abundance of literature demonstrating significant reductions in
markers of HRV in individuals with T2D.

Conclusion
In summary, two acute bouts of ANB had no impact upon HRV in an older, but healthy,
population. There was, however, a significant effect of LNB on resting heart in individuals with
T2D. Given the rapid proliferation of T2D, the established association between vagal modulation
and cardiovascular complications and the relative ease of yogic breathing techniques further
research into the autonomic-modifying effects of pranayama is warranted.
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Table III.1 Log transformed time and frequency domain measurements of heart rate variability
(mean ±SEM)

Mean HR (bpm)

SDNN (ms)

RMSSD (ms)

Total Power (ms2)

CON

T2D

CON

T2D

CON

T2D

CON

T2D

Baseline

69.7±3.43

73.7±4.01

1.91±0.10

1.64±0.33

1,92±0.12

1.53±0.42*

3.67±0.26

3.07±0.21

First
Stand

75.3±2.5

80.1±4.1

2.00±0.13

1.80±0.10

1.87±0.15

1.58±0.15

3.66±0.32

3.08±0.24

Baseline

67.0±2.4

72.0±3.5

2.06±0.08

1.72±0.10
*

2.01±0.11

1.62±0.12*

3.92±0.18

3.30±0.22

LNB

67.4±2.2

70.1±2.8J

1.96±0.08

1.60±0.20
*

1.89±0.11

l.42±0.07*

3.86±0.17

3.07±0.12
*t

Baseline
3

67.5±1.8

70.1±2.9

2.00±0.08

1.63±0.07
*

1,93±0.10

1.47±0.08*

3.95±0.18

3.21±0.13

RNB

67.7±2.0

70.9±3.1

1.94±0.08

1.63±0.08
*

1.88±0.10

1.45±0.09*

3.87±0.21

3.17±0.17
*

Last
Stand

71.4±1.9

79.1±3.4*

2.08±0.10

1.73±0.10
*

2.04±0.11

1.53±0.14*

3.95±0.23

3.22±0.20
*

Overall

68.5±2.4

71.3±2.9

2.03±0.07

1.76±0.06
*

1.97±0.09

1.58±0.08*

3.99±0.19

3.41±0.13
•

2

Mean HR is expressed as beats per minute (bpm), SDNN and RMSSD are expressed as
milliseconds (MS) and total power is expressed as milliseconds squared (MS ). Control subjects,
CON; type 2 diabetic subjects, T2D.
Significant difference vs. CON (p<0.05)
fSignificant difference vs. Last Stand (p<0.05)
J Significant difference vs. Overall Mean HR within T2D (p<0.05)
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Left Nostril

CON SDNN

T2DS0NN

CON RMSSD

T2D RMSSD

Figure III.l. Log transformed SDNN and RMSSD values during left nostril breathing in T2D
compared to CON subjects.
•Significantly different from CON (p<0.05).

Mean HR Stand 2
80

Figure III.2. Mean HR During Stand 2 comparing T2D to CON.
•Significantly different from CON (p<0.05).

I 2.5

Baseline 3

CON

T2D
SDNN

CON

T2D
RMSSD

Figure III.3. Log transformed SDNN and RMSSD during Baseline 3 comparing T2D to
*Significantly different from CON (p<0.05).
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2.5

SDNN of Entire Breathing Protocol
*

1.5

0.5

CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D
Baseline 1

Standi

Baseline 2

LNB

Baseline 3

RNB

Stand 2

Overall

Figure III.4 Log transformed SDNN during entire 39 minute protocol in T2D compared to CON
subjects.
•Significantly different from CON (p<0.05)
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RMSSD of Entire Breathing Protocol

CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D
Baseline 1 Stand 1 Baseline 2

LNB

Baseline 3

RNB

Stand 2

Overall

Figure III.5 Log Transformed RMSSD During Entire 39 Minute Protocol in T2D Compared to
CON Subjects.
*Significantly different from CON (p<0.05)
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4.5

TP of Entire Breathing Protocol
T

*
*

3.5

2.5

1.5

0.5
CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D CON T2D
Baseline 1 Standi

Baseline 2

LNB

Baseline 3

RNB

Stand 2

Overall

Figure III.6 Log transformed TP during entire 39 minute protocol in T2D compared to CON
subjects.
*Significantly different from CON (p<0.05)
fSignificantly different from Last Stand (p<0.05)
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Difference in Mean HR

I 71.5
71
; 70.5
70
I 69.5
69
LNB

OVERALL
T2D Mean HR

Figure III.7. Mean HR in T2D subjects during the left nostril breathing (LNB) compared to the
overall mean HR through the entire breathing protocol.
•Significantly different from Overall mean HR (p<0.05).
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CHAPTER IV

PROJECT II
The Effect of N-Acetyl-5-Methoxytryptamine (Melatonin) on Glucose Homeostasis, Lipid
Metabolism, and Oxidative Stress in Type 2 Diabetes

INTRODUCTION
Complications of type 2 diabetes mellitus (T2D) are believed to result from hyperglycemiadriven increases in oxidative stress. A limited amount of in-vivo evidence indicates a potential
role for melatonin in improving glucose regulation, lipid metabolism and oxidative stress in
T2D. Melatonin, a hormone primarily secreted by the pineal gland, is most often associated with
circadian rhythms and the sleep cycle. It is, however, a potent and unique antioxidant (Korkmaz
et al., 2009) that has demonstrated an ameliorative effect on oxidative stress in human and
animal models of T2D (Kedziora-Kornatowska et al. 2009; Rosales-Corral et al., 2003). Thus,
the purpose of this investigation was to evaluate the effect of a commercially available
preparation of melatonin on glycemic control, lipid metabolism, and oxidative stress in T2D.

METHODS
Fourteen sedentary subjects with uncomplicated T2D (10 female, 4 male; 52.5 ± 5.0 years)
were randomly assigned to a melatonin group (MEL) or placebo group (PLA) for 42 days,
followed by 42 days in the opposite group in a crossover design. Exclusionary criteria included
sleep apnea or other sleep disorders, congestive heart failure, myocardial infarction, arrhythmia
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or any cardiovascular event in the previous year, liver disease, kidney disease, orthostatic
hypotension, or diagnosis of previous or current psychiatric disorder, according to DSM-IV
(American Psychiatric Association, 1994). The study was approved by the Old Dominion
University Institutional Review Board, and subjects provided signed informed consent prior to
their participation.
During each supplementation period, subjects ingested either 10 mg of melatonin in capsule
form (Quality Supplement and Vitamins, Inc., Ft. Lauderdale, FL) 30-60 minutes prior to sleep
or an identical capsule (Capsuline, In., Pompano Beach, FL) containing white flour. Fasting
blood draws occurred on three mornings: prior to supplementation, after 42 days, and after 84
days.

Blood Chemistry Analyses
Blood samples were collected in heparinized tubes using standard venipuncture technique.
Lipids, fasting glucose and A1C were immediately analyzed using enzymatic assays (Cholestech
Corp., Hayward, CA and Siemens Healthcare Diagnostics, Tarrytown, NY, respectively).
Thereafter, samples were frozen and stored prior to spectrophotometric analysis of
malondialdehyde (Zeptometrix Corp., Buffalo, NY)

Statistics
Mean differences were analyzed using a 2-way ANOVA with repeated measures on one
factor (time), whereas one-tailed, paired t-tests were used to assess change from baseline
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between groups. Results are presented as mean ±SEM. Data analyses were performed with
PASW 17.0 (SPSS, Chicago, IL). Results were considered to be statistically significant at P <
0.05.

RESULTS
The change in A1C resulted in a total improvement of 0.33% after 42 days of melatonin
supplementation compared to placebo (-0.24±0.23 % for MEL vs. 0.09±0.21 % for PLA, p=0.01)
(Figure IV.1). After supplementation, levels of plasma malondialdehyde (MDA), a marker of
oxidative stress, were significantly lower for MEL (-6.25±2.10 nmol/ml) compared to PLA
(0.72±3.30, p=0.028) (Figure IV.2). This equates to a 55% reduction in MDA following
melatonin supplementation. No significant changes were noted for total cholesterol, high density
lipoprotein, low density lipoprotein, triglycerides, or fasting plasma glucose.

DISCUSSION
The results of this investigation add to the limited amount of in-vivo evidence demonstrating a
potential role of melatonin in improving glycemic control and decreasing oxidative stress in
T2D. Similar to animal and in-vitro data, the present investigation realized an ameliorative effect
of melatonin supplementation on a marker of oxidative stress, as well as a reduction in long-term
glycemia.
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It is widely accepted that oxidative stress plays a significant role in the pathogenesis of T2D
(Ceriello and Testa, 2009). While there is a strong theoretical background advocating the use of
conventional antioxidant therapy to ameliorate oxidative stress, studies using supplemental
vitamins C, E and beta-carotene have yielded disappointing results (Beckman et al., 2003).
Given the lackluster performance of conventional antioxidants in addressing health-related
outcomes induced by oxidative stress it has been suggested that a "new antioxidant" approach to
oxidative stress should focus on increasing intracellular antioxidant defenses and controlling free
radical formation at its source (Ceriello and Testa, 2009).
The "holy grail" of antioxidants would be capable of directly scavenging free radicals, but
more importantly, it would also be capable of: a) stimulating antioxidative enzymes, b) directly
promoting glutathione synthesis, and c) reducing production of free radicals in the mitochondria.
Evidence from animal models and human in-vitro studies suggests that melatonin is capable of
achieving these results (Reiter et al., 2007). Melatonin differs from conventional antioxidants by
serving both as a direct scavenger of reactive oxygen species (ROS) (Korkmaz et al., 2009) as
well as a potent stimulator of endogenous antioxidant enzymes (Urata et al., 1999).
Interestingly, reductions in plasma melatonin are independently associated with T2D
(Radziuk and Pye, 2006). Consequently, this reduction in circulating melatonin, which is
associated with significantly higher levels of oxidative stress and reduced antioxidant activity in
diabetes (Kedziora-Kornatowska et al., 2009), is likely a direct result of an increased
consumption of melatonin due to hyperglycemia precipitating increased levels of oxidative stress
(Tan et al., 2007).
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Prior to the present investigation, the only study to date that has investigated the effect of
melatonin on oxidative stress in vivo in T2D was conducted in elderly patients (KedzioraKornatowska et al., 2009). Similar to the present investigation, a 5 mg/day dose of melatonin for
30 days resulted in a substantial reduction in MDA (-20%), as well as increasing superoxide
dismutase (+16%), an important intracellular antioxidant defense, and serum melatonin (+70%).
While it is firmly established that oxidative stress is a significant contributing factor to the
pathogenesis of T2D, current therapy remains primarily aimed at pharmacological interventions
that decrease endogenous glucose production, enhance insulin secretion, or decrease insulin
resistance. The current treatment strategy, however, is suboptimal. Diabetic complications are a
direct result of hyperglycemia and hyperglycemia-induced oxidative stress, but it has been
documented that only 37% of patients with T2D maintain an optimal glucose level (Saydah et
al., 2004). Melatonin may hold the potential to be a low-cost adjunctive therapy in the treatment
of complications arising from T2D.

Conclusion
In conclusion, this investigation demonstrated that a single daily dose of 10 mg of melatonin
significantly decreased glycated hemoglobin and oxidative stress in individuals with T2D.
Considering the prevalence and rapid growth of diabetes and the totality of evidence linking
melatonin to reduced oxidative stress and increased antioxidant defenses, it would seem prudent
to further investigate this unique antioxidant.
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Table IV.1 Effects of daily treatment with lOmg melatonin for 6 weeks vs. placebo
(mean ± SEM)

Baseline

Post MEL

Post PLA

A1C (%)

7.26 ±0.30

7.02 ±0.33*

7.35 ±0.37

Fasting Plasma
Glucose (mmol/L)

7.88 ± 0.62

7.36 ± 0.53

7.84 ± 0.99

Total Cholesterol
(mmol/L)

4.43 ±0.31

4.43 ± 0.33

4.43 ± 0.35

LDL Cholesterol
(mmol/L)

2.54 ±0.27

2.38 ± 0.24

2.58 ± 0.29

HDL Cholesterol
(mmol/L)

1.11 ±0.09

1.15 ±0.09

1.07 ±0.09

Triglycerides
(mmol/L)

1.56 ± 0.18

2.06 ± 0.42

1.78 ±0.30

MDA (nmol/ml)

11.5 ± 1.64

5.2 ± 1.22*

12.2 ± 3.30f

Melatonin supplementation, MEL; placebo supp ementation, PLA; plasma malondialdehyde,
MDA.
*Post MEL is significantly different from baseline (p<0.05)
fNon-significant trend between Post PLA and Post MEL (p=.055)
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Change in AlC (%)

Baseline

Figure IV.1. Change in AlC % following 6 weeks of melatonin supplementation (MEL) and
placebo (PLA).
•Significantly different from baseline (p<0.05)
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Change in MDA Concentration
(nmol/ml)
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Baseline

Post MEL

Post PLA

MDA

Figure IV.2. Change in plasma malondialdehyde (MDA) concentration between 6 weeks of
melatonin supplementation and 6 weeks of placebo.
•Significantly different from placebo (p<0.05)
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CHAPTER V

PROJECT III
The Effects of Walking vs. Table Tennis on Postprandial Glycemia, Heart Rate Variability,
and Mood in Type 2 Diabetes

INTRODUCTION
Type 2 diabetes mellitus (T2D) is a widespread epidemic that now affects nearly one out of
every ten Americans (CDC, 2011). Complications arising from T2D represent a significant strain
upon the national healthcare system, accounting for approximately 18.5% of all health care
expenditures (ADA, 2003). Distressingly, the ranks of the diabetic population are swelling
rapidly and it is predicted that the number of people with diabetes will nearly double within the
next three decades (Chaturvedi, 2007). Potentially more troubling, however, is an estimate by the
Centers for Disease Control and Prevention suggesting that 35% of American adults over the age
of 20 years and 50% of adults over the age of 65 years have prediabetes (CDC, 2011).
The treatment of T2D involves optimal regulation of glycemic levels, blood pressure and
lipids, and physical activity is considered a cornerstone treatment and prevention strategy
(Colberg and Grieco, 2009). Regular physical activity (PA) has been shown to improve glycemia
and blood lipid profile, decrease blood pressure, and reduce both cardiovascular events and
overall mortality in T2D (Colberg et al., 2010). Nevertheless, the majority of individuals with
T2D are not regularly active (Morrato et al., 2007). In fact, almost one-third of U.S. adults with
T2D report being completely sedentary, while an additional 38% receive less than the
recommended levels of PA (Nelson et al., 2002). Interestingly, regular physical activity levels

83

among individuals with T2D mirror the maintenance of optimal glycemic levels, which remains
distressingly low at only 37% (Saydah et al., 2004).
The timing of exercise can dramatically impact the glycemic response in T2D. For example,
one hour of aerobic exercise significantly decreased plasma glucose in men with T2D following
a breakfast meal, but had a minimal impact on glycemia when in a fasted state (Poirier et al.,
2001). More recently, Colberg et al. (2009) demonstrated that 20 minutes of mild-to-moderate
intensity walking significantly lowered postprandial glycemia to a greater extent in individuals
with T2D when undertaken after the evening as compared to exercise before the evening meal
(or no exercise).
Autonomic nervous system deterioration is a common complication of T2D that frequently
results in autonomic neuropathy (AN) (Vinik and Erbas, 2001) and prevalence rates have been
reported as high as 100% (Ziegler et al., 1992). A common complication resulting from AN is
reduced heart rate variability (HRV). The HRV represents the time fluctuation in the beat-to-beat
intervals between successive cardiac cycles and is reflective of the dynamic response of the
sympathetic and parasympathetic branches of the autonomic nervous system. This reduction in
HRV has been shown to be an early predictor of macrovascular disease as well as correlating
with carotid artery atherosclerosis in T2D (Gottsater et al., 2006). Alarmingly, there are
detectable deficits in HRV prior to the onset of T2D in the presence of impaired fasting glucose
(Singh et al., 2000).
Decrements of parasympathetic nervous system (PNS) activity appear early in T2D,
contribute to the imbalance between sympathetic and parasympathetic inputs (sympathovagal
balance), and manifest as diastolic dysfunction (Poirier et al., 2003). Vagal activity, however, has
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been shown to increase the cardiac fibrillation threshold, thereby imparting a protective effect
against ventricular tachyarrythmias (Acharya et al., 2006). Importantly, exercise training has
demonstrated significant improvements in HRV and sympathovagal balance in individuals with
T2D (Figueroa et al., 2007; Zoppini et al., 2007; Sridhar et al., 2010).
Walking is perhaps the most commonly prescribed form of PA in T2D. While walking as a
form of exercise has many benefits, individuals with T2D are among the least likely to exercise
on a regular basis; therefore, additional measures are necessary to encourage greater PA levels. A
more recreational form of exercise (i.e., table tennis) may be perceived as being more enjoyable
and, therefore, increase the volume of PA (Williams et al., 2008). No studies to date have
examined the glycemic impact of a more recreational activity like table tennis compared to a
more traditional exercise like walking. Similarly, the differential effects of an acute bout of
standard vs. recreational PA on HRV in T2D are absent from the literature. Thus, the aim of this
study was to compare the impact of a traditionally prescribed exercise (walking) with a more
recreational activity (table tennis) on postprandial glycemia, mood and HRV following the
dinner meal.

METHODS

Subjects
A total of 12 subjects (9 female, 3 male) with uncomplicated T2D treated with diet and/or oral
anti-diabetic medications participated in this investigation. Subject characteristics are presented
in Table V.1. Eleven of the subjects were currently taking oral glucose-lowering drugs and one
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subject was diet only. The study was approved by the Old Dominion University Institutional
Review Board, and subjects provided signed informed consent prior to their participation.

Protocol
Each subject performed one control and two research trials in a randomized order, on
different days. Each trial was approximately 180 minutes in length (Table V.2) and were as
follows: (1) non-exercise control period in which a standardized meal was consumed (CON); (2)
30 minutes of self-paced walking on a motorized treadmill, begun 30 minutes after eating a
standardized meal (TM); (3) 30 minutes of continuous table tennis, played against an iPong
automated table tennis robot (IPONG®, Rockville, MD) (TT), begun 30 minutes after eating a
standardized meal. Each dinner was a microwavable meal of approximately 500 kcals with a
macronutrient ratio representative of a typical American dinner. All participants were seated in a
thermoneutral environment (25-28°C) for the duration of the trial, except during the 30 minutes
of TM or TT. Exercising heart rates were recorded during the last few minutes of the
intervention period. Exercise intensity was calculated as a percentage of age-predicted maximal
heart rate (estimated using 220 minus age).
Baseline blood samples were collected at the beginning of trial one (regardless of which
testing condition was scheduled) using standard venipuncture technique. A full lipid panel,
including total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL)
and triglycerides (TG), as well as glycated hemoglobin (A1C) were analyzed using enzymatic
assays (Cholestech Corp., Hayward, CA and Siemens Healthcare Diagnostics, Tarrytown, NY,
respectively). To measure changes in plasma glucose finger-stick measures of whole blood
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glucose levels were obtained using a Lifescan OneTouch Ultra (Johnson & Johnson, Milpitas,
CA). Measurements were taken at 30-minute intervals, beginning 30 minutes after arrival, for a
total of five plasma glucose measurements.
To quantitatively evaluate changes in mood the Profile of Mood States-Brief (POMS) was
completed before and immediately following each trial intervention (i.e., rest or either exercise).
The POMS-Brief (McNair and Heuchert, 2007), a 30-item self-rating questionnaire, consists of
six dimensions of mood, including: Tension/Anxiety, Depression, Anger/Hostility, Vigor,
Fatigue, and Confusion (C). A value of total mood disturbance (TMD) is calculated by
subtracting the V score from the sum of the remaining scores.

Heart Rate Variability
Measurements of HRV were taken at two time points during each trial, shortly after arrival to
the lab and 30 minutes after the end of the intervention. Subjects were placed in a recumbent
position, instructed to relax, to speak and move as little as possible, and allowed to breathe
spontaneously for a 10-minute period. Heart rate data was recorded using the Polar WearLink
system (Polar, Finland), with a sampling rate of 1000 Hz. HRV measurements were calculated
from the final 5 minutes of the 10-minute rest period. Data was visually inspected on a computer
monitor to minimize presence of artifact. Time and frequency domain measurements were
analyzed using Kubios HRV analysis 2.0 software (University of Kuopio, Kuopio, Finland).
Detrending of raw data was performed according to Tarvainen et al. (2002) and power frequency
analysis was performed using a fast Fourier transform with Welch's periodogram (256s window
with 50% overlap). Time domain HRV measurements included Mean RR interval, SDNN and
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RMSSD. Frequency domain measurements included Low (LF) and high frequency (HF) power
measurements and total power (TP), presented as absolute power (ms2) and normalized units
(n.u.). Normalized LF power is calculated as LF/(total power-VLF)xlOO and HF power as
HF/(total power-VLF)xlOO. LF and HF measurements represent the power of the heart period
power spectrum between 0.04 - 0.15 Hz and 0.15 - 0.40 Hz, respectively. The LF/HF ratio is
calculated as LF (ms2)/HF (ms2).

Autonomic Neuropathy
Measurement of AN was conducted on a separate day and included the following three tests:
Valsalva ratio, E/I (expiration/inspiration) ratio and 30:15 ratio. These measures were obtained
on the subjects during resting conditions using the Anscore System (Boston Medical
Technologies, Wakefield, MA).

Accelerometry
A quantification of total motion was measured using the Biohamess BT (Zephyr Technology,
Annapolis, MD). Each subject was securely fitted with a Biohamess, worn on the chest similar to
a heart rate monitor, prior to the 30-minute collection period. The Biohamess incorporates a
triaxial accelerometer and records in vector magnitude units (VMU) at a sampling rate of 125
Hz, as a 3 dimensional acceleration of g-forces averaged into 1 second epochs.
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Statistics
Mean differences were analyzed using a 2-way ANOVA with repeated measures on one
factor (time). In addition, correlational analyses were performed to examine the relationships
among biometric data, AN values and measurements of HRV. Results are presented as mean
±SEM. Data analyses were performed with PASW 17.0 (SPSS, Chicago, IL). Given that the
HRV data were not normally distributed, all data were logarithmically transformed prior to
analysis to induce normality (except for instantaneous heart rate data). Results were considered
to be statistically significant at P < 0.05.

RESULTS

Characteristics of subjects are presented in Table V.l. Mean heart rate during TM (122.8±5.4
beats per minute) was significantly higher than during TT (96.9±5.0, p=0.05) and CON
(69.1±8.4, p=0.001). The percentage of age-predicted maximum heart rate (%MHR) during TM
(76.4±0.04%) was also significantly higher than both CON (42.9±0.02%) and TT (60.5±0.04%)
(p<0.05) (Figure V.4). TM demonstrated a significantly greater quantity of motion than CON
(91%, p=0.01) and TT (72%, p=0.01) (Figure V.l). There was a significant decrease in
postprandial glycemia in the TM group in comparison to CON (-25%, p=0.018) and TT (-23.5%,
p=0.004) immediately following the bout of exercise, at 90 minutes (Figure V.2). Similarly, the
change in plasma glucose was significantly lower in the TM group (-29.4±8.3 mg/dL) than in the
CON (19.3±6.6 mg/dL, p=0.001) or TT group (12.6±10.4 mg/dL, 0.005) at 90 minutes.
However, 30 minutes after the cessation of exercise, at 120 minutes, the TM group (21.3±5.5
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mg/dL) was significantly higher than the CON (-5.2±5.3 mg/dL, 0.007) or TT (1.1±5.8 mg/dL,
p=0.005) groups, respectively (Figures V.2 and V.3). There was no significant effect of time or
intervention upon mood state.

Time Domain HR V
Mean resting HR during HRV measurements showed significant differences between trials
with a decrease from pre to post in CON (-4 bpm, p=0.005) and a significant increase from pre to
post in TM (6 bpm, p=0.011) (Table V.3). Mean resting HR was significantly lower in CON
during post HRV measurement than either TM (-8.0 bpm, p=0.007) or TT (-5.8 bpm, p=0.007).
The SDNN of the pre TM was significantly higher than the post TM (p=0.039) and post TT
measurements (p=0.039). The RMSSD in CON post was significantly higher than all other trials
(p=0.001) (Table V.3).

Frequency Domain HR V
The CON pre HF (n.u.) was significantly higher than TM pre (p=0.049) and TM pre LF (ms2)
was significantly higher than TT post (p=0.009). There were no significant differences for the
log-transformed LF (n.u.) or the HF (ms2) or for the sympathovagal balance (LF/HF ratio) (Table
V.4).

Correlations with Autonomic Neuropathy
-y
The 30:15 ratio was positively correlated with the TM pre values of LF (ms ) (p=0.045,
r=.587) as well as the TM post SDNN (p=0.046, r=.583). Neither the Valsalva ratio nor the E/I
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ratio were significantly correlated with any time or frequency domain measure of HRV.

Correlations of Demographic and Biometric Data with Time and Frequency Domain HRV
No measurement of time domain frequency was significantly correlated with age, BMI, body
fat percentage, A1C, or length of diagnosis. The HF (ms ) of TM post was significantly
negatively correlated with length of diagnosis (p=0.032, r=-0.619). Similarly, length of diagnosis
was also negatively correlated with the HF (n.u.) of TT post (p=0.04, r=-0.597). Unadjusted
correlation (non-log transformed) between time and frequency domain measurements were non
significant.

DISCUSSION

The present investigation examined the differential effects of two different styles of aerobic
exercise following an identical dinner meal on mood, postprandial glycemia, and HRV.
Postprandial walking resulted in a significant dip in plasma glucose immediately following 30
minutes of exercise at a self-selected pace. This decrease was, however, somewhat offset by a
rebound spike in plasma glucose in the TM group 30 minutes after the cessation of exercise that
was absent in the TT and CON groups. Exercise selection had no effect on mood. While the
differential effects of exercise on HRV were minimal, there was a significant suppressive effect
of recent exercise (independent of style) on vagal stimulation (RMSSD).
To our knowledge this was the first study to examine the differential effects of a recreational
vs. standard aerobic exercise on postprandial glycemia. While there was a significant
postprandial decrease in plasma glucose immediately following TM exercise, there was also a
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rebound effect present at 120 minutes (30 minutes post-exercise), with the TM group
demonstrating significantly higher plasma glucose than the CON or TT groups. This effect is
likely due to the different self-selected intensities sustained during TM and TT (76.4 vs. 60.5%
MHR). While the higher intensity achieved during the TM protocol was likely responsible for
the post-exercise spike in plasma glucose at 120 minutes, it should be noted that glucose levels at
150 minutes were not significantly different among groups.
The timing of meals and exercise plays an important role in optimal glycemic control. The
ability of postprandial exercise to attenuate blood glucose excursions has been well documented.
For example, it was recently reported that 20 minutes of moderate-intensity self-paced walking
(~40% of heart rate reserve) had a greater glycemic impact on individuals with T2D when
performed following the dinner meal than when it occurred prior to the dinner meal (Colberg et
al., 2009). Similarly, Larsen et al. (1997) found that a single 45 minute bout of cycling exercise
conducted at -50% VC^max following the breakfast meal significantly reduced blood glucose
area under the curve for a four hour period following the cessation of exercise in comparison to a
non-exercise control period. This increase in glucose uptake, however, occurred in the presence
of a significant decrease in insulin secretion. This apparent contradiction is explainable when
considering two important pieces of evidence: 1) the onset of exercise increases sympathetic
tone, resulting in an attenuation of insulin secretion (Borer, 2003), and 2) exercise is known to
increase skeletal muscle glucose uptake independent of insulin action (lessen and Goodyear,
2005).
The onset of exercise induces both a nervous and hormonal response, resulting in an increase
in catecholamine secretion, primarily in the form of epinephrine (De Glisezinski et al., 2009),
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which mobilizes glucose in an intensity-dependent manner (Kjaer, 1989), while simultaneously
suppressing insulin action. The extra effort put forth during the TM protocol, as assessed through
percentage of age-predicted maximum heart rate, was such that glucose disposal was likely
temporarily increased while stimulating a latent increase in epinephrine secretion that became
apparent with the over-shoot of plasma glucose levels at 120 minutes. Moreover, the higher
exercise intensity in the TM group would have caused a shift in substrate utilization away from
free fatty acids and toward greater glucose usage, which could explain the significant dip in
plasma glucose at 90 minutes in the TM group, the subsequent rebound at 120 minutes, and the
rapid attenuation of glucose levels at 150 minutes.
Glycemic control is the most important aspect in the treatment of T2D and the common goal
of treatment is the overall reduction of plasma glucose to a level that is considered normal.
Several large scale clinical trials have demonstrated that improvements in long-term glycemic
control (A1C) are associated with decreases in micro- and macrovascular complications
(UKPDS, 1998; Shichiri et al., 2000). However, the potentially deleterious role that postprandial
excursions play in T2D is significant and an accumulating amount of evidence suggests that
postprandial spikes may play a prominent role in the pathology of T2D. For example,
postprandial glucose levels have been implicated as an important antecedent in the onset and
progression of nephropathy in T2D (Shichiri et al., 2005). In another study, Woerle et al. (2007)
investigated the relative contribution of fasting and postprandial glucose levels on overall
glycemic control in 164 individuals with T2D. Results demonstrated that postprandial glycemia
is a more significant contributor to A1C levels than fasting glucose. Therefore, strategies
specifically targeting postprandial excursions may represent a more focused treatment
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intervention, potentially increasing the importance of exercise in the amelioration of
complications arising from T2D.
Previous studies on the chronic effect of aerobic exercise on HRV in T2D have demonstrated
positive adaptations resulting in improved sympathovagal balance and increased vagal
modulation. For example, Zoppini et al. (2007) found that a twice-weekly moderate-intensity
aerobic exercise regimen conducted for six months increased vagal output while decreasing
sympathetic output (measured as high and low frequency power, respectively) in individuals
with uncomplicated T2D. These results, however, were only noted during a systemic challenge
(response to standing); thus, there was no change in measures of HRV conducted at rest.
Similarly, Figueroa et al. (2007) found that neither obese (but normoglycemic) nor T2D females
improved resting measurements of HRV following 16 weeks of thrice weekly walking at ~ 65%
of VO2 peak. They did, however, demonstrate significant increases in both LF and HF power
post-training when HRV measurements were taken following an acute bout of 20 minutes of
treadmill walking at 65% of VO2 peak. However, no previous studies have investigated the acute
effect of a single bout of exercise on resting HRV values in T2D.
While it can be stated that chronic exercise training imparts a cardio-autonomic benefit in
T2D, the measurement of those beneficial effects appear to be limited to periods in which there
is (or has been) a cardiovascular challenge (i.e., response to standing or soon after a bout of
exercise). Interestingly, there appears to be no improvement in cardio-autonomic function as a
result of chronic exercise training that is measurable in a rested state in T2D. In the present study
we investigated the acute effect of a bout of exercise on HRV, conducted approximately 30
minutes after the cessation of exercise. The primary finding was a residual suppression of
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parasympathetic drive (RMSSD) in both exercise groups that was absent in the control group.
Therefore, the findings of this investigation support no improvement of measures of HRV
following an acute bout of exercise.

Conclusion
In summary, the present study found that 30 minutes of self-paced walking following the
dinner meal may be more effective at lowering postprandial glycemia in individuals with T2D
than a similar duration of table tennis. We did not, however, find that a more recreational form of
exercise (i.e., table tennis) improved affective response, suggesting that traditionally prescribed
exercise (i.e., walking) has no significant negative impact on mood and was superior to table
tennis in postprandial glycemic control. Exercise also fails to produce an acute impact on
measures of HRV. Despite the demonstrated improvement of HRV following chronic exercise
training, it appears that a single bout of exercise does nothing more than contribute to a lingering
suppression of vagal modulation following 30 minutes of exercise in T2D. Nevertheless, given
the totality of available evidence, including the present investigation, exercise is strongly
recommended as a method of postprandial glycemic control as well as eliciting improvements in
cardio-autonomic modulation in T2D.
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Table V.l Subject baseline characteristics (mean ± SEM)
All

Males

Females

Subjects (#)

12

3

9

Age (years)

58.7±2.4

64.0±4.6

55.7±2.9

Weight (lb)

211.4±13.0

191.1±15.7

218.2±16.4

Height (in)

65.7±0.7

69.2±1.0

64.4±0.4

Body mass index

34.8±2.4

28.1±2.4

37.1±2.8

Body fat (%)

39.5±2.8

27.7±3.5

43.5±2.3

Diabetes duration (yrs)

6.1±1.4

7.7±3.2

5.6±1.6

A1C (%)

6.6±0.2

6.4±0.3

6.7±0.2

Cholesterol (mg/dL)

149.5±14.2

112.0±6.7

162.0±16.9

HDL-Chol. (mg/dL)

40.0±4.9

23.7±0.9

45.4±5.4

Triglycerides (mg/dL)

143.8±21.3

190.7±44.3

128.2±23.4

Table V.2. Testing procedures timetable

5:00 - 6:00 pm
Time
(min)

0

30

6:00 - 7:00 pm

7:00-8:00 pm

60

90

120

150

180

CON

HRV/POMS Dinner

30
min
Rest

POMS

HRV

Rest

Rest

TM

HRV/POMS Dinner

30
min
TM

POMS

HRV

Rest

Rest

TT

HRV/POMS Dinner

30
min
TT

POMS

HRV

Rest

Rest

Table V.3. Log transformed time domain measurements of heart rate variability

CON
Mean RR
(ms)

Pre
869.1 +
123.7

TT

TM

Post
916.7 +
120.5'

Pre
895.9 +
131.6

Post
822 +
122.82

Pre
867.8 +
129.1

Post
849.2 +
128.4

74.5 +
10.7

70.8 +
10.8

72.3 +
10.6

Mean HR
(bpm)

70.5 +
10.0

66.5 + 8.1J

68.5 + 10.0

SDNN

1.36+0.05

1.36+0.08

1.37+0.086,7 1.26+0.07 1.36+0.08 1.26+0.07

RMSSD

1.38+0.075 3.17+0.224

1.36+0.11

1.26+0.09 1.38+0.09 1.26+0.09

Values are means ± SEM for rest (RE), treadmill (TM) and table tennis (TT) groups.
'Significant difference vs. CON pre (p<0.05)
Significant difference vs. CON post (p< 0.05)
Significant difference vs. CON pre (p< 0.05)
Significant difference vs. all other trials (p<0.05)
Significant difference vs. CON post (p<0.05)
Significant difference vs. TM post (p<0.05)
Significant difference vs. TT post (p<0.05)

Table V.4. Log transformed frequency domain measurements of heart rate variability

LF (ms2)

CON
Pre
Post
2.20±0.10
2.26±0.17

LF (n.u.)

1.66±0.06

1.63±0.07

1.64±0.09

1.66±0.08 1.58±0.09 1.59±0.09

HF (ms2)

2.18±0.17

2.27±0.17

2.17±0.24

1.96±0.18

HF (n.u.)

1.64±0.08

1.65±0.08

1.53±0.10

1.58±0.10 1.62±0.10

1.62±0.11

TP (ms2)

2.560.11

2.64±0.15

2.68±0.18''2 2.41±0.15 2.64±0.15

2.41±0.15

LF/HF

1.8 ± 2.1

1.7 ±2.0

TM
TT
Pre
Post
Pre
Post
2.30±0.17 2.03±0.17 2.24±0.14 2.02±0.15

2.9 ±3.3

2.6 ±3.2

2.29±0.19 2.05±0.24

2.4 ±3.5

2.8 ±4.7

Values are means ± SEM for control (CON), treadmill (TM) and table tennis (TT) groups.
'Significant difference vs. TM post (p<0.05)
Significant difference vs. TT post (p<0.05)
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Figure V.1. Physical activity in vector magnitude units (VMU) of rest (CON), 30 minutes of selfpaced treadmill walking (TM) and table tennis (TT) groups.
All 12 subjects are shown individually by number.
•Significant difference vs. CON (p<0.05)
•(•Significant difference vs. TT (p<0.05)
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Figure V.2 Change in plasma glucose in response to standardized meal with no exercise (CON),
30 minutes of self-paced treadmill walking (TM), or continuous table tennis (TT).
*Significantly different vs. CON and TT (p<0.05)
•("Significantly different vs. CON and TT (p<0.05)
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Figure V.3 Change in plasma glucose at 90 and 120 minutes with no exercise (CON), 30 minutes
of self-paced walking on a treadmill (TM), or continuous table tennis (TT).
•Significantly higher than TM-90 (p<0.05)
fSignificantly lower than TM-120 (p<0.05)
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CHAPTER VI

CONCLUSIONS
The prevalence of T2D has reached epidemic proportions in the United States. Nearly 100
million Americans have, or are at increased risk of developing, T2D. Current treatment strategies
fall far short of preventing or adequately treating this insidious disease. Alternative and
adjunctive therapies are needed to more capably treat this chronic disease.
The projects included within this dissertation investigated three distinct alternative therapies
for the treatment of T2D. The first project examined the efficacy of a little known aspect of yoga.
Yoga is an ancient form of physical and mental discipline and has been growing rapidly in
popularity within the U.S. Furthermore, yoga has been associated with a decreased exercise
dropout rate. Pranayama, a collective term referring to yogic breathing exercises, have long been
touted to have an ability to alter autonomic function. The previous research investigating the
effect of pranayama has been equivocal and no studies have previously examined these effects in
T2D. Our results indicated pranayama had no impact upon cardio-autonomic function. While
yoga training is a viable and valuable form of exercise it appears that yogic breathing exercises
do not positively impact autonomic function in individuals with T2D.
A widely accepted hypothesis suggests that oxidative stress may be the most important factor
contributing to complications arising from diabetes. Following this logic antioxidant compounds
should play a vital role in delaying or preventing diabetic complications. While there is a paucity
of research investigating this possibility in T2D similar investigations examining the relationship
of the most common vitamin-based antioxidants with cardiovascular disease prevention have
yielded disappointing results. Melatonin, however, differs from the conventional class of
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antioxidants by serving both as a direct scavenger as well as a potent stimulator of endogenous
antioxidant enzymes. While there is a substantial amount of research that has investigated the
efficacy of melatonin as a quencher of oxidative stress in animal models and in vitro lines, there
is a near absence of in vivo research. Importantly, we found a significant impact of melatonin
supplementation on markers of oxidative stress, as well improving the long-term glycemic
profile of individuals with T2D. Melatonin, therefore, may be a viable adjunctive and/or
alternative therapy for its treatment.
Individuals with T2D have been shown to have a very low exercise participation rate.
Complications arising from diabetes result from hyperglycemia-driven processes. Therefore,
reducing hyperglycemia is of paramount importance. Exercise has demonstrated an important
ability to reduce both acute and chronic glycemic levels. However, it has been found recently
that controlling postprandial glycemic spikes may be more important than reducing fasting blood
glucose levels. Therefore, the timing of an exercise intervention may play a prominent role in
modifying health outcomes in these individuals. Our project investigated the differential effects
of a traditional exercise prescription and a more recreational form of exercise on postprandial
glycemia. Our findings demonstrated that postprandial walking was more effective than table
tennis in lowering plasma glucose levels following a standardized meal. We did not, however,
find any improvement in affective response attributable to recreational exercise, indicating that
walking may be a preferred method of exercise for most individuals with this disease. In
conclusion, the results of these projects have demonstrated the efficacy of non-pharmaceutical
forms of treatment as adjunctive and/or alternative therapy in T2D.
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